<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="">

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc"><meta name="ncbi_pdid" content="article"><meta name="ncbi_acc" content=""><meta name="ncbi_domain" content="brain"><meta name="ncbi_report" content="record"><meta name="ncbi_type" content="fulltext"><meta name="ncbi_objectid" content=""><meta name="ncbi_pcid" content="/articles/PMC4408440/"><meta name="ncbi_app" content="pmc">
        <!-- Logger end -->
        
        <title>Genetic variants are major determinants of CSF antibody levels in multiple sclerosis</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css"><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE"><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408440/"><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/"><meta name="citation_journal_title" content="Brain"><meta name="citation_title" content="Genetic variants are major determinants of CSF antibody levels in multiple sclerosis"><meta name="citation_authors" content="An Goris, Ine Pauwels, Marte W. Gustavsen, Brechtje van Son, Kelly Hilven, Steffan D. Bos, Elisabeth Gulowsen Celius, Pål Berg-Hansen, Jan Aarseth, Kjell-Morten Myhr, Sandra D’Alfonso, Nadia Barizzone, Maurizio A. Leone, Filippo Martinelli Boneschi, Melissa Sorosina, Giuseppe Liberatore, Ingrid Kockum, Tomas Olsson, Jan Hillert, Lars Alfredsson, Sahl Khalid Bedri, Bernhard Hemmer, Dorothea Buck, Achim Berthele, Benjamin Knier, Viola Biberacher, Vincent van Pesch, Christian Sindic, Annette Bang Oturai, Helle Bach Søndergaard, Finn Sellebjerg, Poul Erik H. Jensen, Manuel Comabella, Xavier Montalban, Jennifer Pérez-Boza, Sunny Malhotra, Jeannette Lechner-Scott, Simon Broadley, Mark Slee, Bruce Taylor, Allan G. Kermode, Pierre-Antoine Gourraud, International Multiple Sclerosis Genetics Consortium, Stephen J. Sawcer, Bettina Kullle Andreassen, Bénédicte Dubois, Hanne F. Harbo"><meta name="citation_date" content="March 2015"><meta name="citation_issue" content="3"><meta name="citation_volume" content="138"><meta name="citation_firstpage" content="632"><meta name="citation_doi" content="10.1093/brain/awu405"><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4408440/?report=abstract"><meta name="citation_pmid" content="25616667"><meta name="DC.Title" content="Genetic variants are major determinants of CSF antibody levels in multiple sclerosis"><meta name="DC.Type" content="Text"><meta name="DC.Publisher" content="Oxford University Press"><meta name="DC.Contributor" content="An Goris"><meta name="DC.Contributor" content="Ine Pauwels"><meta name="DC.Contributor" content="Marte W. Gustavsen"><meta name="DC.Contributor" content="Brechtje van Son"><meta name="DC.Contributor" content="Kelly Hilven"><meta name="DC.Contributor" content="Steffan D. Bos"><meta name="DC.Contributor" content="Elisabeth Gulowsen Celius"><meta name="DC.Contributor" content="Pål Berg-Hansen"><meta name="DC.Contributor" content="Jan Aarseth"><meta name="DC.Contributor" content="Kjell-Morten Myhr"><meta name="DC.Contributor" content="Sandra D’Alfonso"><meta name="DC.Contributor" content="Nadia Barizzone"><meta name="DC.Contributor" content="Maurizio A. Leone"><meta name="DC.Contributor" content="Filippo Martinelli Boneschi"><meta name="DC.Contributor" content="Melissa Sorosina"><meta name="DC.Contributor" content="Giuseppe Liberatore"><meta name="DC.Contributor" content="Ingrid Kockum"><meta name="DC.Contributor" content="Tomas Olsson"><meta name="DC.Contributor" content="Jan Hillert"><meta name="DC.Contributor" content="Lars Alfredsson"><meta name="DC.Contributor" content="Sahl Khalid Bedri"><meta name="DC.Contributor" content="Bernhard Hemmer"><meta name="DC.Contributor" content="Dorothea Buck"><meta name="DC.Contributor" content="Achim Berthele"><meta name="DC.Contributor" content="Benjamin Knier"><meta name="DC.Contributor" content="Viola Biberacher"><meta name="DC.Contributor" content="Vincent van Pesch"><meta name="DC.Contributor" content="Christian Sindic"><meta name="DC.Contributor" content="Annette Bang Oturai"><meta name="DC.Contributor" content="Helle Bach Søndergaard"><meta name="DC.Contributor" content="Finn Sellebjerg"><meta name="DC.Contributor" content="Poul Erik H. Jensen"><meta name="DC.Contributor" content="Manuel Comabella"><meta name="DC.Contributor" content="Xavier Montalban"><meta name="DC.Contributor" content="Jennifer Pérez-Boza"><meta name="DC.Contributor" content="Sunny Malhotra"><meta name="DC.Contributor" content="Jeannette Lechner-Scott"><meta name="DC.Contributor" content="Simon Broadley"><meta name="DC.Contributor" content="Mark Slee"><meta name="DC.Contributor" content="Bruce Taylor"><meta name="DC.Contributor" content="Allan G. Kermode"><meta name="DC.Contributor" content="Pierre-Antoine Gourraud"><meta name="DC.Contributor" content="International Multiple Sclerosis Genetics Consortium"><meta name="DC.Contributor" content="Stephen J. Sawcer"><meta name="DC.Contributor" content="Bettina Kullle Andreassen"><meta name="DC.Contributor" content="Bénédicte Dubois"><meta name="DC.Contributor" content="Hanne F. Harbo"><meta name="DC.Date" content="2015 Mar"><meta name="DC.Identifier" content="10.1093/brain/awu405"><meta name="DC.Language" content="en"><meta property="og:title" content="Genetic variants are major determinants of CSF antibody levels in multiple sclerosis"><meta property="og:type" content="article"><meta property="og:description" content="Immunological hallmarks of multiple sclerosis include the production of antibodies in the central nervous system, expressed as presence of oligoclonal bands and/or an increased immunoglobulin G index—the level of immunoglobulin G in the cerebrospinal ..."><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408440/"><meta property="og:site_name" content="PubMed Central (PMC)"><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png"><meta name="twitter:card" content="summary"><meta name="twitter:site" content="@ncbi"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css"><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print"><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'"><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css"><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-brain.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content=""><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4408440/epub/"><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4408440/pdf/awu405.pdf">

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico"><meta name="ncbi_phid" content="CE898D1DDD5765C10000000008210504.m_8">
<meta name="referrer" content="origin-when-cross-origin"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css"><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print"><script async="1" src="https://www.google-analytics.com/analytics.js"></script><style type="text/css">.MathJax_Preview {color: #888}
#MathJax_Message {position: fixed; left: 1px; bottom: 2px; background-color: #E6E6E6; border: 1px solid #959595; margin: 0px; padding: 2px 8px; z-index: 102; color: black; font-size: 80%; width: auto; white-space: nowrap}
#MathJax_MSIE_Frame {position: absolute; top: 0; left: 0; width: 0px; z-index: 101; border: 0px; margin: 0px; padding: 0px}
.MathJax_Error {color: #CC0000; font-style: italic}
</style><style type="text/css">.MathJax_Hover_Frame {border-radius: .25em; -webkit-border-radius: .25em; -moz-border-radius: .25em; -khtml-border-radius: .25em; box-shadow: 0px 0px 15px #83A; -webkit-box-shadow: 0px 0px 15px #83A; -moz-box-shadow: 0px 0px 15px #83A; -khtml-box-shadow: 0px 0px 15px #83A; border: 1px solid #A6D ! important; display: inline-block; position: absolute}
.MathJax_Menu_Button .MathJax_Hover_Arrow {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 4px; -webkit-border-radius: 4px; -moz-border-radius: 4px; -khtml-border-radius: 4px; font-family: 'Courier New',Courier; font-size: 9px; color: #F0F0F0}
.MathJax_Menu_Button .MathJax_Hover_Arrow span {display: block; background-color: #AAA; border: 1px solid; border-radius: 3px; line-height: 0; padding: 4px}
.MathJax_Hover_Arrow:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_Hover_Arrow:hover span {background-color: #CCC!important}
</style><style type="text/css">#MathJax_Zoom {position: absolute; background-color: #F0F0F0; overflow: auto; display: block; z-index: 301; padding: .5em; border: 1px solid black; margin: 0; font-weight: normal; font-style: normal; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; -webkit-box-sizing: content-box; -moz-box-sizing: content-box; box-sizing: content-box; box-shadow: 5px 5px 15px #AAAAAA; -webkit-box-shadow: 5px 5px 15px #AAAAAA; -moz-box-shadow: 5px 5px 15px #AAAAAA; -khtml-box-shadow: 5px 5px 15px #AAAAAA; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_ZoomOverlay {position: absolute; left: 0; top: 0; z-index: 300; display: inline-block; width: 100%; height: 100%; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
#MathJax_ZoomFrame {position: relative; display: inline-block; height: 0; width: 0}
#MathJax_ZoomEventTrap {position: absolute; left: 0; top: 0; z-index: 302; display: inline-block; border: 0; padding: 0; margin: 0; background-color: white; opacity: 0; filter: alpha(opacity=0)}
</style><style type="text/css">#MathJax_About {position: fixed; left: 50%; width: auto; text-align: center; border: 3px outset; padding: 1em 2em; background-color: #DDDDDD; color: black; cursor: default; font-family: message-box; font-size: 120%; font-style: normal; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 15px; -webkit-border-radius: 15px; -moz-border-radius: 15px; -khtml-border-radius: 15px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
#MathJax_About.MathJax_MousePost {outline: none}
.MathJax_Menu {position: absolute; background-color: white; color: black; width: auto; padding: 5px 0px; border: 1px solid #CCCCCC; margin: 0; cursor: default; font: menu; text-align: left; text-indent: 0; text-transform: none; line-height: normal; letter-spacing: normal; word-spacing: normal; word-wrap: normal; white-space: nowrap; float: none; z-index: 201; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; -khtml-border-radius: 5px; box-shadow: 0px 10px 20px #808080; -webkit-box-shadow: 0px 10px 20px #808080; -moz-box-shadow: 0px 10px 20px #808080; -khtml-box-shadow: 0px 10px 20px #808080; filter: progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color='gray', Positive='true')}
.MathJax_MenuItem {padding: 1px 2em; background: transparent}
.MathJax_MenuArrow {position: absolute; right: .5em; padding-top: .25em; color: #666666; font-size: .75em}
.MathJax_MenuActive .MathJax_MenuArrow {color: white}
.MathJax_MenuArrow.RTL {left: .5em; right: auto}
.MathJax_MenuCheck {position: absolute; left: .7em}
.MathJax_MenuCheck.RTL {right: .7em; left: auto}
.MathJax_MenuRadioCheck {position: absolute; left: .7em}
.MathJax_MenuRadioCheck.RTL {right: .7em; left: auto}
.MathJax_MenuLabel {padding: 1px 2em 3px 1.33em; font-style: italic}
.MathJax_MenuRule {border-top: 1px solid #DDDDDD; margin: 4px 3px}
.MathJax_MenuDisabled {color: GrayText}
.MathJax_MenuActive {background-color: #606872; color: white}
.MathJax_MenuDisabled:focus, .MathJax_MenuLabel:focus {background-color: #E8E8E8}
.MathJax_ContextMenu:focus {outline: none}
.MathJax_ContextMenu .MathJax_MenuItem:focus {outline: none}
#MathJax_AboutClose {top: .2em; right: .2em}
.MathJax_Menu .MathJax_MenuClose {top: -10px; left: -10px}
.MathJax_MenuClose {position: absolute; cursor: pointer; display: inline-block; border: 2px solid #AAA; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; font-family: 'Courier New',Courier; font-size: 24px; color: #F0F0F0}
.MathJax_MenuClose span {display: block; background-color: #AAA; border: 1.5px solid; border-radius: 18px; -webkit-border-radius: 18px; -moz-border-radius: 18px; -khtml-border-radius: 18px; line-height: 0; padding: 8px 0 6px}
.MathJax_MenuClose:hover {color: white!important; border: 2px solid #CCC!important}
.MathJax_MenuClose:hover span {background-color: #CCC!important}
.MathJax_MenuClose:hover:focus {outline: none}
</style></head>
    <body class="article" id="ui-ncbiexternallink-3"><div id="MathJax_Message" style="display: none;"></div>
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list ui-ncbibasicmenu orientation_hort" id="navcontent" role="menubar"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt" role="presentation"><a class="ui-ncbimenu-link-first" href="/" role="menuitem" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo"></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources" tabindex="-1" role="menuitem">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first" role="presentation"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto" tabindex="-1" role="menuitem">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi" style="top: -0.4em;"><iframe src="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/emyncbi.fcgi?cmd=htmlportal&amp;currenturl=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408440%2F" style="border:none; height:2.5em; width:40em;" scrolling="no"></iframe></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br>
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><div class="jig-ncbiclearbutton-wrap ui-ncbiclearbutton-wrap box-shadow"><input name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" aria-haspopup="true" aria-autocomplete="list" role="textbox" type="text"><a class="reset" href="#" style="visibility: hidden;"><img src="/core/jig/1.14.8/img/clear.png" alt="Clear input"></a></div></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=%22Brain%22[journal]" class="navlink">Brain</a></li><li class="accid">PMC4408440</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-brain.gif" alt="Logo of brain" usemap="#logo-imagemap"><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="10,40,143,75" alt="Instructions to Authors" title="Instructions to Authors" href="http://www.oxfordjournals.org/page/6235/7" ref="reftype=publisher&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="144,40,197,75" alt="Subcribe" title="Subcribe" href="http://www.oxfordjournals.org/page/6235/6" ref="reftype=publisher&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="198,40,239,75" alt="About" title="About" href="http://www.oxfordjournals.org/page/6235/8" ref="reftype=publisher&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="240,40,321,75" alt="Free Editorials" title="Free Editorials" href="http://www.oxfordjournals.org/page/6235/9" ref="reftype=publisher&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"><area shape="rect" coords="0,0,500,75" alt="Brain" title="Brain" href="http://brain.oxfordjournals.org/" ref="reftype=publisher&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext"></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'" id="ui-ncbiinpagenav-1"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span role="menubar"><a href="#" role="menuitem" aria-expanded="false" aria-haspopup="true">Brain</a></span>. 2015 Mar; 138(3): 632–643. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Jan 23. </span>  <span class="doi">doi:&nbsp;<a href="//dx.doi.org/10.1093%2Fbrain%2Fawu405" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1093/brain/awu405</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4408440</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/25616667">25616667</a></div></div></div></div><h1 class="content-title">Genetic variants are major determinants of CSF antibody levels in multiple sclerosis</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Goris%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961361527360" co-class="co-affbox">An Goris</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup><sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Pauwels%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961316631600" co-class="co-affbox">Ine Pauwels</a>,<sup>1,</sup><sup>*</sup> <a href="/pubmed/?term=Gustavsen%20MW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961322977648" co-class="co-affbox">Marte W. Gustavsen</a>,<sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=van%20Son%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961284524656" co-class="co-affbox">Brechtje van Son</a>,<sup>4</sup> <a href="/pubmed/?term=Hilven%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961286310448" co-class="co-affbox">Kelly Hilven</a>,<sup>1</sup> <a href="/pubmed/?term=Bos%20SD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961286308336" co-class="co-affbox">Steffan D. Bos</a>,<sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=Celius%20EG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961361712736" co-class="co-affbox">Elisabeth Gulowsen Celius</a>,<sup>2</sup> <a href="/pubmed/?term=Berg-Hansen%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961320128016" co-class="co-affbox">Pål Berg-Hansen</a>,<sup>2,</sup><sup>3</sup> <a href="/pubmed/?term=Aarseth%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961287089008" co-class="co-affbox">Jan Aarseth</a>,<sup>5</sup> <a href="/pubmed/?term=Myhr%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961282792736" co-class="co-affbox">Kjell-Morten Myhr</a>,<sup>5,</sup><sup>6</sup> <a href="/pubmed/?term=D%26%23x02019%3BAlfonso%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961275261296" co-class="co-affbox">Sandra D’Alfonso</a>,<sup>7,</sup><sup>8</sup> <a href="/pubmed/?term=Barizzone%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961281998080" co-class="co-affbox">Nadia Barizzone</a>,<sup>7</sup> <a href="/pubmed/?term=Leone%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961322658064" co-class="co-affbox">Maurizio A. Leone</a>,<sup>8,</sup><sup>9</sup> <a href="/pubmed/?term=Martinelli%20Boneschi%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285203168" co-class="co-affbox">Filippo Martinelli Boneschi</a>,<sup>10,</sup><sup>11</sup> <a href="/pubmed/?term=Sorosina%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285181088" co-class="co-affbox">Melissa Sorosina</a>,<sup>11</sup> <a href="/pubmed/?term=Liberatore%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961358133184" co-class="co-affbox">Giuseppe Liberatore</a>,<sup>10,</sup><sup>11</sup> <a href="/pubmed/?term=Kockum%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285346320" co-class="co-affbox">Ingrid Kockum</a>,<sup>12</sup> <a href="/pubmed/?term=Olsson%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961287514896" co-class="co-affbox">Tomas Olsson</a>,<sup>12</sup> <a href="/pubmed/?term=Hillert%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961315213024" co-class="co-affbox">Jan Hillert</a>,<sup>13</sup> <a href="/pubmed/?term=Alfredsson%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961315210912" co-class="co-affbox">Lars Alfredsson</a>,<sup>14</sup> <a href="/pubmed/?term=Bedri%20SK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285905872" co-class="co-affbox">Sahl Khalid Bedri</a>,<sup>13</sup> <a href="/pubmed/?term=Hemmer%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285092832" co-class="co-affbox">Bernhard Hemmer</a>,<sup>15,</sup><sup>16</sup> <a href="/pubmed/?term=Buck%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961317859152" co-class="co-affbox">Dorothea Buck</a>,<sup>15</sup> <a href="/pubmed/?term=Berthele%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961282006112" co-class="co-affbox">Achim Berthele</a>,<sup>15</sup> <a href="/pubmed/?term=Knier%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961317451328" co-class="co-affbox">Benjamin Knier</a>,<sup>15</sup> <a href="/pubmed/?term=Biberacher%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961317449216" co-class="co-affbox">Viola Biberacher</a>,<sup>15</sup> <a href="/pubmed/?term=van%20Pesch%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285633776" co-class="co-affbox">Vincent van Pesch</a>,<sup>17</sup> <a href="/pubmed/?term=Sindic%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285631440" co-class="co-affbox">Christian Sindic</a>,<sup>17</sup> <a href="/pubmed/?term=Bang%20Oturai%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961324194256" co-class="co-affbox">Annette Bang Oturai</a>,<sup>18</sup> <a href="/pubmed/?term=S%26%23x000f8%3Bndergaard%20HB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961324192144" co-class="co-affbox">Helle Bach Søndergaard</a>,<sup>18</sup> <a href="/pubmed/?term=Sellebjerg%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961275561264" co-class="co-affbox">Finn Sellebjerg</a>,<sup>18</sup> <a href="/pubmed/?term=Jensen%20PE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961280562080" co-class="co-affbox">Poul Erik H. Jensen</a>,<sup>18</sup> <a href="/pubmed/?term=Comabella%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961284048928" co-class="co-affbox">Manuel Comabella</a>,<sup>19</sup> <a href="/pubmed/?term=Montalban%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961284046816" co-class="co-affbox">Xavier Montalban</a>,<sup>19</sup> <a href="/pubmed/?term=P%26%23x000e9%3Brez-Boza%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961320351536" co-class="co-affbox">Jennifer Pérez-Boza</a>,<sup>19</sup> <a href="/pubmed/?term=Malhotra%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961316045040" co-class="co-affbox">Sunny Malhotra</a>,<sup>19</sup> <a href="/pubmed/?term=Lechner-Scott%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961280718032" co-class="co-affbox">Jeannette Lechner-Scott</a>,<sup>20</sup> <a href="/pubmed/?term=Broadley%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961287503728" co-class="co-affbox">Simon Broadley</a>,<sup>21</sup> <a href="/pubmed/?term=Slee%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961320125488" co-class="co-affbox">Mark Slee</a>,<sup>22</sup> <a href="/pubmed/?term=Taylor%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961320123152" co-class="co-affbox">Bruce Taylor</a>,<sup>23</sup> <a href="/pubmed/?term=Kermode%20AG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961359405024" co-class="co-affbox">Allan G. Kermode</a>,<sup>24,</sup><sup>25</sup> <a href="/pubmed/?term=Gourraud%20PA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961285781280" co-class="co-affbox">Pierre-Antoine Gourraud</a>,<sup>26</sup> International Multiple Sclerosis Genetics Consortium,<sup>#</sup> <a href="/pubmed/?term=Sawcer%20SJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961360543920" co-class="co-affbox">Stephen J. Sawcer</a>,<sup>27</sup> <a href="/pubmed/?term=Andreassen%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961322625504" co-class="co-affbox">Bettina Kullle Andreassen</a>,<sup>28</sup> <a href="/pubmed/?term=Dubois%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961282076112" co-class="co-affbox">Bénédicte Dubois</a>,<sup>1,</sup><sup>4</sup> and  <a href="/pubmed/?term=Harbo%20HF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667" class="affpopup" co-rid="_co_idm139961357720016" co-class="co-affbox">Hanne F. Harbo</a><sup>2,</sup><sup>3</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139961361527360"><h3 class="no_margin">An Goris</h3><p>1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Goris%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">An Goris</a></div></div><div id="_co_idm139961316631600"><h3 class="no_margin">Ine Pauwels</h3><p>1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Pauwels%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Ine Pauwels</a></div></div><div id="_co_idm139961322977648"><h3 class="no_margin">Marte W. Gustavsen</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><p>3 Institute of Clinical Medicine, University of Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Gustavsen%20MW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Marte W. Gustavsen</a></div></div><div id="_co_idm139961284524656"><h3 class="no_margin">Brechtje van Son</h3><p>4 Department of Neurology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=van%20Son%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Brechtje van Son</a></div></div><div id="_co_idm139961286310448"><h3 class="no_margin">Kelly Hilven</h3><p>1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Hilven%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Kelly Hilven</a></div></div><div id="_co_idm139961286308336"><h3 class="no_margin">Steffan D. Bos</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><p>3 Institute of Clinical Medicine, University of Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Bos%20SD%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Steffan D. Bos</a></div></div><div id="_co_idm139961361712736"><h3 class="no_margin">Elisabeth Gulowsen Celius</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Celius%20EG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Elisabeth Gulowsen Celius</a></div></div><div id="_co_idm139961320128016"><h3 class="no_margin">Pål Berg-Hansen</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><p>3 Institute of Clinical Medicine, University of Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Berg-Hansen%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Pål Berg-Hansen</a></div></div><div id="_co_idm139961287089008"><h3 class="no_margin">Jan Aarseth</h3><p>5 Norwegian MS-Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway</p><div>Find articles by <a href="/pubmed/?term=Aarseth%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Jan Aarseth</a></div></div><div id="_co_idm139961282792736"><h3 class="no_margin">Kjell-Morten Myhr</h3><p>5 Norwegian MS-Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway</p><p>6 KG Jebsen Centre for MS-research, Department of Clinical Medicine, University of Bergen, Bergen, Norway</p><div>Find articles by <a href="/pubmed/?term=Myhr%20KM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Kjell-Morten Myhr</a></div></div><div id="_co_idm139961275261296"><h3 class="no_margin">Sandra D’Alfonso</h3><p>7 Department of Health Sciences, University of Eastern Piedmont, Novara, Italy</p><p>8 Interdisciplinary Research Centre of Autoimmune Diseases IRCAD, University of Eastern Piedmont, Novara, Italy</p><div>Find articles by <a href="/pubmed/?term=D%26%23x02019%3BAlfonso%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Sandra D’Alfonso</a></div></div><div id="_co_idm139961281998080"><h3 class="no_margin">Nadia Barizzone</h3><p>7 Department of Health Sciences, University of Eastern Piedmont, Novara, Italy</p><div>Find articles by <a href="/pubmed/?term=Barizzone%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Nadia Barizzone</a></div></div><div id="_co_idm139961322658064"><h3 class="no_margin">Maurizio A. Leone</h3><p>8 Interdisciplinary Research Centre of Autoimmune Diseases IRCAD, University of Eastern Piedmont, Novara, Italy</p><p>9 Neurology Unit, Scientific Institute, Hospital ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo, Italy</p><div>Find articles by <a href="/pubmed/?term=Leone%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Maurizio A. Leone</a></div></div><div id="_co_idm139961285203168"><h3 class="no_margin">Filippo Martinelli Boneschi</h3><p>11 Laboratory of Genetics of Neurological Complex Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</p><div>Find articles by <a href="/pubmed/?term=Martinelli%20Boneschi%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Filippo Martinelli Boneschi</a></div></div><div id="_co_idm139961285181088"><h3 class="no_margin">Melissa Sorosina</h3><p>11 Laboratory of Genetics of Neurological Complex Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</p><div>Find articles by <a href="/pubmed/?term=Sorosina%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Melissa Sorosina</a></div></div><div id="_co_idm139961358133184"><h3 class="no_margin">Giuseppe Liberatore</h3><p>10 Department of Neuro-rehabilitation, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</p><p>11 Laboratory of Genetics of Neurological Complex Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</p><div>Find articles by <a href="/pubmed/?term=Liberatore%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Giuseppe Liberatore</a></div></div><div id="_co_idm139961285346320"><h3 class="no_margin">Ingrid Kockum</h3><p>12 Neuroimmunology Unit, Department of Clinical Neuroscience, Centrum for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Kockum%20I%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Ingrid Kockum</a></div></div><div id="_co_idm139961287514896"><h3 class="no_margin">Tomas Olsson</h3><p>12 Neuroimmunology Unit, Department of Clinical Neuroscience, Centrum for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Olsson%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Tomas Olsson</a></div></div><div id="_co_idm139961315213024"><h3 class="no_margin">Jan Hillert</h3><p>13 Multiple Sclerosis Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Hillert%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Jan Hillert</a></div></div><div id="_co_idm139961315210912"><h3 class="no_margin">Lars Alfredsson</h3><p>14 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Alfredsson%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Lars Alfredsson</a></div></div><div id="_co_idm139961285905872"><h3 class="no_margin">Sahl Khalid Bedri</h3><p>13 Multiple Sclerosis Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</p><div>Find articles by <a href="/pubmed/?term=Bedri%20SK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Sahl Khalid Bedri</a></div></div><div id="_co_idm139961285092832"><h3 class="no_margin">Bernhard Hemmer</h3><p>15 Department of Neurology, Technische Universität München, Munich, Germany</p><p>16 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany</p><div>Find articles by <a href="/pubmed/?term=Hemmer%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Bernhard Hemmer</a></div></div><div id="_co_idm139961317859152"><h3 class="no_margin">Dorothea Buck</h3><p>15 Department of Neurology, Technische Universität München, Munich, Germany</p><div>Find articles by <a href="/pubmed/?term=Buck%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Dorothea Buck</a></div></div><div id="_co_idm139961282006112"><h3 class="no_margin">Achim Berthele</h3><p>15 Department of Neurology, Technische Universität München, Munich, Germany</p><div>Find articles by <a href="/pubmed/?term=Berthele%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Achim Berthele</a></div></div><div id="_co_idm139961317451328"><h3 class="no_margin">Benjamin Knier</h3><p>15 Department of Neurology, Technische Universität München, Munich, Germany</p><div>Find articles by <a href="/pubmed/?term=Knier%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Benjamin Knier</a></div></div><div id="_co_idm139961317449216"><h3 class="no_margin">Viola Biberacher</h3><p>15 Department of Neurology, Technische Universität München, Munich, Germany</p><div>Find articles by <a href="/pubmed/?term=Biberacher%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Viola Biberacher</a></div></div><div id="_co_idm139961285633776"><h3 class="no_margin">Vincent van Pesch</h3><p>17 Institute of Neurosciences, Neurochemistry Unit, Université Catholique de Louvain-la-Neuve, Louvain-la-Neuve, Belgium</p><div>Find articles by <a href="/pubmed/?term=van%20Pesch%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Vincent van Pesch</a></div></div><div id="_co_idm139961285631440"><h3 class="no_margin">Christian Sindic</h3><p>17 Institute of Neurosciences, Neurochemistry Unit, Université Catholique de Louvain-la-Neuve, Louvain-la-Neuve, Belgium</p><div>Find articles by <a href="/pubmed/?term=Sindic%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Christian Sindic</a></div></div><div id="_co_idm139961324194256"><h3 class="no_margin">Annette Bang Oturai</h3><p>18 Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark</p><div>Find articles by <a href="/pubmed/?term=Bang%20Oturai%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Annette Bang Oturai</a></div></div><div id="_co_idm139961324192144"><h3 class="no_margin">Helle Bach Søndergaard</h3><p>18 Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark</p><div>Find articles by <a href="/pubmed/?term=S%26%23x000f8%3Bndergaard%20HB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Helle Bach Søndergaard</a></div></div><div id="_co_idm139961275561264"><h3 class="no_margin">Finn Sellebjerg</h3><p>18 Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark</p><div>Find articles by <a href="/pubmed/?term=Sellebjerg%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Finn Sellebjerg</a></div></div><div id="_co_idm139961280562080"><h3 class="no_margin">Poul Erik H. Jensen</h3><p>18 Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark</p><div>Find articles by <a href="/pubmed/?term=Jensen%20PE%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Poul Erik H. Jensen</a></div></div><div id="_co_idm139961284048928"><h3 class="no_margin">Manuel Comabella</h3><p>19 Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d’Hebron (VHIR), Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=Comabella%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Manuel Comabella</a></div></div><div id="_co_idm139961284046816"><h3 class="no_margin">Xavier Montalban</h3><p>19 Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d’Hebron (VHIR), Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=Montalban%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Xavier Montalban</a></div></div><div id="_co_idm139961320351536"><h3 class="no_margin">Jennifer Pérez-Boza</h3><p>19 Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d’Hebron (VHIR), Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=P%26%23x000e9%3Brez-Boza%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Jennifer Pérez-Boza</a></div></div><div id="_co_idm139961316045040"><h3 class="no_margin">Sunny Malhotra</h3><p>19 Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d’Hebron (VHIR), Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain</p><div>Find articles by <a href="/pubmed/?term=Malhotra%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Sunny Malhotra</a></div></div><div id="_co_idm139961280718032"><h3 class="no_margin">Jeannette Lechner-Scott</h3><p>20 Hunter Medical Research Institute, University of Newcastle, Australia</p><div>Find articles by <a href="/pubmed/?term=Lechner-Scott%20J%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Jeannette Lechner-Scott</a></div></div><div id="_co_idm139961287503728"><h3 class="no_margin">Simon Broadley</h3><p>21 School of Medicine, Gold Coast Campus, Griffith University QLD 4222, Australia</p><div>Find articles by <a href="/pubmed/?term=Broadley%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Simon Broadley</a></div></div><div id="_co_idm139961320125488"><h3 class="no_margin">Mark Slee</h3><p>1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Slee%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Mark Slee</a></div></div><div id="_co_idm139961320123152"><h3 class="no_margin">Bruce Taylor</h3><p>23 Menzies Research Institute, University of Tasmania, Hobart, Australia</p><div>Find articles by <a href="/pubmed/?term=Taylor%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Bruce Taylor</a></div></div><div id="_co_idm139961359405024"><h3 class="no_margin">Allan G. Kermode</h3><p>24 Institute of Immunology and Infectious Diseases, Murdoch University, Australia</p><p>25 Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australia</p><div>Find articles by <a href="/pubmed/?term=Kermode%20AG%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Allan G. Kermode</a></div></div><div id="_co_idm139961285781280"><h3 class="no_margin">Pierre-Antoine Gourraud</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Gourraud%20PA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Pierre-Antoine Gourraud</a></div></div><div id="_co_idm139961360543920"><h3 class="no_margin">Stephen J. Sawcer</h3><p>27 Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK</p><div>Find articles by <a href="/pubmed/?term=Sawcer%20SJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Stephen J. Sawcer</a></div></div><div id="_co_idm139961322625504"><h3 class="no_margin">Bettina Kullle Andreassen</h3><p>28 Department of Molecular Biology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Andreassen%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Bettina Kullle Andreassen</a></div></div><div id="_co_idm139961282076112"><h3 class="no_margin">Bénédicte Dubois</h3><p>1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</p><p>4 Department of Neurology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium</p><div>Find articles by <a href="/pubmed/?term=Dubois%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Bénédicte Dubois</a></div></div><div id="_co_idm139961357720016"><h3 class="no_margin">Hanne F. Harbo</h3><p>2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</p><p>3 Institute of Clinical Medicine, University of Oslo, Norway</p><div>Find articles by <a href="/pubmed/?term=Harbo%20HF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=25616667">Hanne F. Harbo</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139961282916160_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139961282916160_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139961282916160_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139961282916160_ai" style="display:none"><div class="fm-affl" id="awu405-AFF1" lang="en">1 Laboratory for Neuroimmunology, Section of Experimental Neurology, Department of Neurosciences, KU Leuven - University of Leuven, Leuven, Belgium</div><div class="fm-affl" id="awu405-AFF2" lang="en">2 Department of Neurology, Oslo University Hospital Ullevål, Oslo, Norway</div><div class="fm-affl" id="awu405-AFF3" lang="en">3 Institute of Clinical Medicine, University of Oslo, Norway</div><div class="fm-affl" id="awu405-AFF4" lang="en">4 Department of Neurology, University Hospitals Leuven, KU Leuven - University of Leuven, Leuven, Belgium</div><div class="fm-affl" id="awu405-AFF5" lang="en">5 Norwegian MS-Registry and Biobank, Department of Neurology, Haukeland University Hospital, Bergen, Norway</div><div class="fm-affl" id="awu405-AFF6" lang="en">6 KG Jebsen Centre for MS-research, Department of Clinical Medicine, University of Bergen, Bergen, Norway</div><div class="fm-affl" id="awu405-AFF7" lang="en">7 Department of Health Sciences, University of Eastern Piedmont, Novara, Italy</div><div class="fm-affl" id="awu405-AFF8" lang="en">8 Interdisciplinary Research Centre of Autoimmune Diseases IRCAD, University of Eastern Piedmont, Novara, Italy</div><div class="fm-affl" id="awu405-AFF9" lang="en">9 Neurology Unit, Scientific Institute, Hospital ‘Casa Sollievo della Sofferenza’, San Giovanni Rotondo, Italy</div><div class="fm-affl" id="awu405-AFF10" lang="en">10 Department of Neuro-rehabilitation, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</div><div class="fm-affl" id="awu405-AFF11" lang="en">11 Laboratory of Genetics of Neurological Complex Disorders, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy</div><div class="fm-affl" id="awu405-AFF12" lang="en">12 Neuroimmunology Unit, Department of Clinical Neuroscience, Centrum for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden</div><div class="fm-affl" id="awu405-AFF13" lang="en">13 Multiple Sclerosis Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden</div><div class="fm-affl" id="awu405-AFF14" lang="en">14 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden</div><div class="fm-affl" id="awu405-AFF15" lang="en">15 Department of Neurology, Technische Universität München, Munich, Germany</div><div class="fm-affl" id="awu405-AFF16" lang="en">16 Munich Cluster for Systems Neurology (SyNergy), Munich, Germany</div><div class="fm-affl" id="awu405-AFF17" lang="en">17 Institute of Neurosciences, Neurochemistry Unit, Université Catholique de Louvain-la-Neuve, Louvain-la-Neuve, Belgium</div><div class="fm-affl" id="awu405-AFF18" lang="en">18 Danish Multiple Sclerosis Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark</div><div class="fm-affl" id="awu405-AFF19" lang="en">19 Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (Cemcat), Institut de Recerca Vall d’Hebron (VHIR), Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain</div><div class="fm-affl" id="awu405-AFF20" lang="en">20 Hunter Medical Research Institute, University of Newcastle, Australia</div><div class="fm-affl" id="awu405-AFF21" lang="en">21 School of Medicine, Gold Coast Campus, Griffith University QLD 4222, Australia</div><div class="fm-affl" id="awu405-AFF22" lang="en">22 School of Medicine, Flinders University of South Australia, Australia</div><div class="fm-affl" id="awu405-AFF23" lang="en">23 Menzies Research Institute, University of Tasmania, Hobart, Australia</div><div class="fm-affl" id="awu405-AFF24" lang="en">24 Institute of Immunology and Infectious Diseases, Murdoch University, Australia</div><div class="fm-affl" id="awu405-AFF25" lang="en">25 Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Australia</div><div class="fm-affl" id="awu405-AFF26" lang="en">26 Department of Neurology, School of Medicine, University of California San Francisco, USA</div><div class="fm-affl" id="awu405-AFF27" lang="en">27 Department of Clinical Neurosciences, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK</div><div class="fm-affl" id="awu405-AFF28" lang="en">28 Department of Molecular Biology, Institute of Clinical Medicine, University of Oslo, Oslo, Norway</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author"></sup>Corresponding author.</div><div id="awu405-COR1">Correspondence to: Dr An Goris, Laboratory for Neuroimmunology, Department of Neurosciences, KU Leuven - University of Leuven, Herestraat 49 bus 1022, B-3000 Leuven, Belgium E-mail: <a href="mailto:dev@null" data-email="eb.nevueluk.dem@sirog.na" class="oemail">eb.nevueluk.dem@sirog.na</a></div><div id="awu405-FN1">*These authors contributed equally to this work.</div><div id="awu405-FN2"><sup>#</sup>See online <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary material</a> for IMSGC membership list.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139961282916160_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2014 Jul 4; Revised 2014 Oct 2; Accepted 2014 Nov 16.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139961282916160_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> © The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC4408440/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139961284889376" class="tsec sec" lang="en"><div class="goto jig-ncbiinpagenav-goto-container"><span role="menubar"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="menuitem" aria-expanded="false" aria-haspopup="true">Go to:</a></span></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139961284889376title">Abstract</h2><!--article-meta--><div><p id="__p4" class="p p-first-last">Immunological hallmarks of multiple sclerosis include the production of antibodies in the central nervous system, expressed as presence of oligoclonal bands and/or an increased immunoglobulin G index—the level of immunoglobulin G in the cerebrospinal fluid compared to serum. However, the underlying differences between oligoclonal band-positive and -negative patients with multiple sclerosis and reasons for variability in immunoglobulin G index are not known. To identify genetic factors influencing the variation in the antibody levels in the cerebrospinal fluid in multiple sclerosis, we have performed a genome-wide association screen in patients collected from nine countries for two traits, presence or absence of oligoclonal bands (<em>n = </em>3026) and immunoglobulin G index levels (<em>n = </em>938), followed by a replication in 3891 additional patients. We replicate previously suggested association signals for oligoclonal band status in the major histocompatibility complex region for the rs9271640*A-rs6457617*G haplotype, correlated with HLA-DRB1*1501, and rs34083746*G, correlated with HLA-DQA1*0301 (<em>P</em> comparing two haplotypes = 8.88 × 10<sup>−16</sup>). Furthermore, we identify a novel association signal of rs9807334, near the <em>ELAC1</em>/<em>SMAD4</em> genes, for oligoclonal band status (<em>P</em> = 8.45 × 10<sup>−7</sup>). The previously reported association of the immunoglobulin heavy chain locus with immunoglobulin G index reaches strong evidence for association in this data set (<em>P</em> = 3.79 × 10<sup>−37</sup>). We identify two novel associations in the major histocompatibility complex region with immunoglobulin G index: the rs9271640*A-rs6457617*G haplotype (<em>P</em> = 1.59 × 10<sup>−22</sup>), shared with oligoclonal band status, and an additional independent effect of rs6457617*G (<em>P</em> = 3.68 × 10<sup>−6</sup>). Variants identified in this study account for up to 2-fold differences in the odds of being oligoclonal band positive and 7.75% of the variation in immunoglobulin G index. Both traits are associated with clinical features of disease such as female gender, age at onset and severity. This is the largest study population so far investigated for the genetic influence on antibody levels in the cerebrospinal fluid in multiple sclerosis, including 6950 patients. We confirm that genetic factors underlie these antibody levels and identify both the major histocompatibility complex and immunoglobulin heavy chain region as major determinants.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">multiple sclerosis, CSF, oligoclonal bands, immunoglobulin, genetics</span></div></div><div id="__sec1" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec1title">Introduction</h2><p id="__p5" class="p p-first">Multiple sclerosis is a neurological disease characterized by inflammation, demyelination and axonal degeneration, and is an important cause of disability in young adults (<a href="#awu405-B6" rid="awu405-B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166042">Compston and Coles, 2008</a>). The aetiology is not known, but both genetic and environmental factors influence disease susceptibility (<a href="#awu405-B6" rid="awu405-B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166050">Compston and Coles, 2008</a>). An association between multiple sclerosis and the human leukocyte antigen (HLA) genes in the major histocompatibility complex (MHC) region was identified early on (<a href="#awu405-B20" rid="awu405-B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165969">Jersild <em>et al.</em>, 1972</a>), and was later refined to four independent association signals of which HLA-DRB1*15:01 is the strongest (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166017">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). Recently, knowledge of non-HLA associations in multiple sclerosis has increased extensively and immunologically relevant genes are overrepresented among those mapping close to the identified risk variants (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166038">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>; <a href="#awu405-B47" rid="awu405-B47" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165985">The International Multiple Sclerosis Genetics Consortium, 2013</a>).</p><p id="__p6">An immunological hallmark in multiple sclerosis is the finding of oligoclonal bands (OCBs) and/or increased immunoglobulin G (IgG) index in the CSF (<a href="#awu405-B44" rid="awu405-B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166019">Stangel <em>et al.</em>, 2013</a>). OCBs are reported to be observed in 90–95% of patients in Northern Europe, and are composed predominantly of IgG. The IgG index contrasts the CSF/serum IgG ratio to the CSF/serum albumin ratio (<a href="#awu405-B24" rid="awu405-B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166030">Link and Huang, 2006</a>). There are strong indications that antibody levels in the CSF are influenced by genetic factors, as CSF abnormalities are seen in 19% of unaffected siblings of patients with multiple sclerosis as opposed to 4% of healthy unrelated individuals (<a href="#awu405-B13" rid="awu405-B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165973">Haghighi <em>et al.</em>, 2000</a>). Also, the OCB positive rates, as well as the IgG index are reported to correlate with ethnicity (<a href="#awu405-B10" rid="awu405-B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166018">Fukazawa <em>et al.</em>, 1998</a>; <a href="#awu405-B21" rid="awu405-B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166043">Kikuchi <em>et al.</em>, 2003</a>; <a href="#awu405-B39" rid="awu405-B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165995">Rinker <em>et al.</em>, 2007</a>; <a href="#awu405-B22" rid="awu405-B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166027">Lechner-Scott <em>et al.</em>, 2011</a>; <a href="#awu405-B51" rid="awu405-B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166021">Yoshimura <em>et al.</em>, 2014</a>), although not observed in all studies (<a href="#awu405-B2" rid="awu405-B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165970">Berg-Hansen <em>et al.</em>, 2013</a>).</p><p id="__p7">The role of the HLA loci in determining OCB status has been highlighted previously (<a href="#awu405-B10" rid="awu405-B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165997">Fukazawa <em>et al.</em>, 1998</a>; <a href="#awu405-B21" rid="awu405-B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166013">Kikuchi <em>et al.</em>, 2003</a>; <a href="#awu405-B18" rid="awu405-B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166039">Imrell <em>et al.</em>, 2006</a>; <a href="#awu405-B17" rid="awu405-B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166022">Idiman <em>et al.</em>, 2009</a>; <a href="#awu405-B50" rid="awu405-B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165994">Wu <em>et al.</em>, 2009</a>; <a href="#awu405-B40" rid="awu405-B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166037">Romero-Pinel <em>et al.</em>, 2011</a>; <a href="#awu405-B23" rid="awu405-B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166011">Leone <em>et al.</em>, 2013</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165953">Mero <em>et al.</em>, 2013</a>; <a href="#awu405-B51" rid="awu405-B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165977">Yoshimura <em>et al.</em>, 2014</a>). Most recently, large study populations from Scandinavia and Italy have shown HLA-DRB1*15∶01 to be associated with OCB-positive and HLA-DRB1*04∶04 with OCB-negative multiple sclerosis (<a href="#awu405-B23" rid="awu405-B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165966">Leone <em>et al.</em>, 2013</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166015">Mero <em>et al.</em>, 2013</a>). Furthermore, the immunoglobulin heavy chain (IGHC) region was recently reported to be highly correlated with IgG index in German and Belgian patients with multiple sclerosis (<a href="#awu405-B3" rid="awu405-B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166020">Buck <em>et al.</em>, 2012</a>).</p><p id="__p8" class="p p-last">In the present study we aim to further determine the genetic impact on IgG levels in the CSF in multiple sclerosis. We combine genome-wide single nucleotide polymorphism (SNP) data (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166002">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>) with available CSF data in a meta-analysis of 3059 patients with multiple sclerosis and replicate top-hits from the screening phase in 3891 additional samples. The combined data set of 6950 patients from nine countries is the largest study population so far to investigate both clinical and genetic factors associated with OCB status and IgG index and we replicate three previously described associations and identify three new genetic differences underlying CSF phenotypes.</p></div><div id="__sec2" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec2title">Materials and methods</h2><div id="__sec3" class="sec sec-first"><h3 id="__sec3title">Study populations</h3><p id="__p9" class="p p-first-last">The 3059 multiple sclerosis samples included in the screening phase of this study are a subset of the samples that were previously used in a genome-wide association study on multiple sclerosis susceptibility (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165959">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). Eight countries provided OCB status (positive or negative) for 3026 patients in the screening phase, while five countries provided IgG index for 938 patients (<a href="/pmc/articles/PMC4408440/table/awu405-T1/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T1" rid-ob="ob-awu405-T1" co-legend-rid=""><span>Table 1</span></a>). In the replication phase, 3891 additional multiple sclerosis samples (3842 with OCB status and 2188 with IgG index) were provided by eight countries. The combined screening and replication cohort included OCB status on 6868 patients and IgG index on 3126 patients from the following countries: Australia, Belgium, Denmark, Germany, Italy, Norway, Spain, Sweden and USA (<a href="/pmc/articles/PMC4408440/table/awu405-T1/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T1" rid-ob="ob-awu405-T1" co-legend-rid=""><span>Table 1</span></a>). For 3044 patients, both OCB status and IgG index were available. For the genetic analyses, 3478 patients with OCB status and 2072 patients with IgG index survived genetic quality control in the replication phase, leading to a final sample size of 6504 for OCB status and 3010 for IgG index in the combined genetic analyses.
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="awu405-T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p10">Demographic characterization of the multiple sclerosis study populations</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961320339152" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th colspan="1" rowspan="1">Country</th><th colspan="1" rowspan="1">Female:male ratio</th><th colspan="1" rowspan="1">PP (%)</th><th colspan="1" rowspan="1">Age at onset, years, mean (range)</th><th colspan="1" rowspan="1">MSSS mean (range)</th><th colspan="1" rowspan="1">OCB (<em>n</em>)</th><th colspan="1" rowspan="1">OCB+ (%)</th><th colspan="1" rowspan="1">IgG (<em>n</em>)</th><th colspan="1" rowspan="1">IgG index mean (range)</th><th colspan="1" rowspan="1">IgG+ (%)</th><th colspan="1" rowspan="1">Disease duration at lumbar puncture, years, median (range)</th></tr></thead><tbody align="left"><tr><td colspan="1" rowspan="1"><strong>SCREEN (<em>n = </em>3059)</strong></td><td colspan="1" rowspan="1"><strong>2.28</strong></td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1"><strong>33 (9–60)</strong></td><td colspan="1" rowspan="1"><strong>4.43 (0.03–9.98)</strong></td><td colspan="1" rowspan="1"><strong>3026</strong></td><td colspan="1" rowspan="1"><strong>88</strong></td><td colspan="1" rowspan="1"><strong>938</strong></td><td colspan="1" rowspan="1"><strong>1.05 (0.29–7.27)</strong></td><td colspan="1" rowspan="1"><strong>64</strong></td><td colspan="1" rowspan="1"><strong>1 (−6–49)</strong></td></tr><tr><td colspan="1" rowspan="1">Belgium (<em>n = </em>358)</td><td colspan="1" rowspan="1">1.93</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">34 (9–60)</td><td colspan="1" rowspan="1">5.31 (0.03–9.98)</td><td colspan="1" rowspan="1">356</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">165</td><td colspan="1" rowspan="1">1.12 (0.43–5.36)</td><td colspan="1" rowspan="1">68</td><td colspan="1" rowspan="1">2 (−2–46)</td></tr><tr><td colspan="1" rowspan="1">Denmark (<em>n = </em>197)</td><td colspan="1" rowspan="1">2.28</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">32 (12–59)</td><td colspan="1" rowspan="1">4.30 (0.11–9.76)</td><td colspan="1" rowspan="1">189</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">63</td><td colspan="1" rowspan="1">1.24 (0.42–7.27)</td><td colspan="1" rowspan="1">87</td><td colspan="1" rowspan="1">0 (0–39)</td></tr><tr><td colspan="1" rowspan="1">Italy (<em>n = </em>565)</td><td colspan="1" rowspan="1">1.80</td><td colspan="1" rowspan="1">30</td><td colspan="1" rowspan="1">33 (10–60)</td><td colspan="1" rowspan="1">4.47 (0.04–9.96)</td><td colspan="1" rowspan="1">564</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">133</td><td colspan="1" rowspan="1">0.90 (0.34–3.19)</td><td colspan="1" rowspan="1">46</td><td colspan="1" rowspan="1">1 (0–41)</td></tr><tr><td colspan="1" rowspan="1">Norway (<em>n = </em>827)</td><td colspan="1" rowspan="1">2.56</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">34 (10–59)</td><td colspan="1" rowspan="1">5.09 (0.26–9.86)</td><td colspan="1" rowspan="1">827</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">3 (0–41)</td></tr><tr><td colspan="1" rowspan="1">Spain (<em>n = </em>62)</td><td colspan="1" rowspan="1">1.42</td><td colspan="1" rowspan="1">41</td><td colspan="1" rowspan="1">33 (10–60)</td><td colspan="1" rowspan="1">5.57 (0.21–9.83)</td><td colspan="1" rowspan="1">62</td><td colspan="1" rowspan="1">79</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">4 (0–20)</td></tr><tr><td colspan="1" rowspan="1">Sweden (<em>n = </em>443)</td><td colspan="1" rowspan="1">2.52</td><td colspan="1" rowspan="1">4</td><td colspan="1" rowspan="1">33 (12–57)</td><td colspan="1" rowspan="1">3.01 (0.04–9.96)</td><td colspan="1" rowspan="1">439</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">355</td><td colspan="1" rowspan="1">1.00 (0.3–5)</td><td colspan="1" rowspan="1">61</td><td colspan="1" rowspan="1">1 (–6–49)</td></tr><tr><td colspan="1" rowspan="1">Germany (<em>n = </em>444)</td><td colspan="1" rowspan="1">2.67</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">35 (15–58)</td><td colspan="1" rowspan="1">4.70 (0.11–9.84)</td><td colspan="1" rowspan="1">426</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">222</td><td colspan="1" rowspan="1">1.06 (0.29–3.94)</td><td colspan="1" rowspan="1">73</td><td colspan="1" rowspan="1">4 (0–19)</td></tr><tr><td colspan="1" rowspan="1">USA (<em>n = </em>163)</td><td colspan="1" rowspan="1">2.70</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">34 (13–60)</td><td colspan="1" rowspan="1">5.54 (0.74–9.88)</td><td colspan="1" rowspan="1">163</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">3 (0–36)</td></tr><tr><td colspan="11" rowspan="1"><hr></td></tr><tr><td colspan="1" rowspan="1"><strong>REP (<em>n = </em>3891)</strong></td><td colspan="1" rowspan="1"><strong>2.27</strong></td><td colspan="1" rowspan="1"><strong>10</strong></td><td colspan="1" rowspan="1"><strong>34 (2–72)</strong></td><td colspan="1" rowspan="1"><strong>3.95 (0.03–9.96)</strong></td><td colspan="1" rowspan="1"><strong>3842</strong></td><td colspan="1" rowspan="1"><strong>87</strong></td><td colspan="1" rowspan="1"><strong>2188</strong></td><td colspan="1" rowspan="1"><strong>1.03 (0.06–6.20)</strong></td><td colspan="1" rowspan="1"><strong>64</strong></td><td colspan="1" rowspan="1"><strong>1 (−6–48)</strong></td></tr><tr><td colspan="1" rowspan="1">Australia (<em>n = </em>343)</td><td colspan="1" rowspan="1">3.05</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">35 (2–64)</td><td colspan="1" rowspan="1">4.08 (0.05–9.88)</td><td colspan="1" rowspan="1">343</td><td colspan="1" rowspan="1">71</td><td colspan="1" rowspan="1">127</td><td colspan="1" rowspan="1">0.98 (0.06–3.1)</td><td colspan="1" rowspan="1">61</td><td colspan="1" rowspan="1">1 (0–48)</td></tr><tr><td colspan="1" rowspan="1">Belgium (<em>n = </em>359)</td><td colspan="1" rowspan="1">1.92</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">35 (11–72)</td><td colspan="1" rowspan="1">4.16 (0.03–9.94)</td><td colspan="1" rowspan="1">356</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">243</td><td colspan="1" rowspan="1">1.09 (0.37–4.45)</td><td colspan="1" rowspan="1">69</td><td colspan="1" rowspan="1">1 (0–44)</td></tr><tr><td colspan="1" rowspan="1">Denmark (<em>n = </em>274)</td><td colspan="1" rowspan="1">1.98</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">32 (14–61)</td><td colspan="1" rowspan="1">4.15 (0.04–9.63)</td><td colspan="1" rowspan="1">274</td><td colspan="1" rowspan="1">93</td><td colspan="1" rowspan="1">274</td><td colspan="1" rowspan="1">1.27 (0.35–6.20)</td><td colspan="1" rowspan="1">77</td><td colspan="1" rowspan="1">2 (−1–32)</td></tr><tr><td colspan="1" rowspan="1">Italy (<em>n = </em>759)</td><td colspan="1" rowspan="1">2.15</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">31 (7–66)</td><td colspan="1" rowspan="1">3.25 (0.09–9.86)</td><td colspan="1" rowspan="1">759</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">512</td><td colspan="1" rowspan="1">0.89 (0.24–2.97)</td><td colspan="1" rowspan="1">55</td><td colspan="1" rowspan="1">1 (0–35)</td></tr><tr><td colspan="1" rowspan="1">Norway (<em>n = </em>1127)</td><td colspan="1" rowspan="1">2.49</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">34 (12–68)</td><td colspan="1" rowspan="1">4.47 (0.13–9.95)</td><td colspan="1" rowspan="1">1127</td><td colspan="1" rowspan="1">89</td><td colspan="1" rowspan="1">85</td><td colspan="1" rowspan="1">1.26 (0.4–5.5)</td><td colspan="1" rowspan="1">82</td><td colspan="1" rowspan="1">3 (0–38)</td></tr><tr><td colspan="1" rowspan="1">Spain (<em>n = </em>242)</td><td colspan="1" rowspan="1">1.81</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">32 (13–65)</td><td colspan="1" rowspan="1">4.39 (0.15–9.96)</td><td colspan="1" rowspan="1">242</td><td colspan="1" rowspan="1">81</td><td colspan="1" rowspan="1">161</td><td colspan="1" rowspan="1">1.10 (0.4–5.53)</td><td colspan="1" rowspan="1">65</td><td colspan="1" rowspan="1">1 (0–40)</td></tr><tr><td colspan="1" rowspan="1">Sweden (<em>n = </em>380)</td><td colspan="1" rowspan="1">2.65</td><td colspan="1" rowspan="1">12</td><td colspan="1" rowspan="1">38 (12–68)</td><td colspan="1" rowspan="1">4.97 (0.10–9.87)</td><td colspan="1" rowspan="1">380</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">379</td><td colspan="1" rowspan="1">1.03 (0.3–3.8)</td><td colspan="1" rowspan="1">68</td><td colspan="1" rowspan="1">0 (−6–44)</td></tr><tr><td colspan="1" rowspan="1">Germany (<em>n = </em>407)</td><td colspan="1" rowspan="1">1.99</td><td colspan="1" rowspan="1">3</td><td colspan="1" rowspan="1">33 (12–64)</td><td colspan="1" rowspan="1">3.40 (0.10–9.77)</td><td colspan="1" rowspan="1">361</td><td colspan="1" rowspan="1">91</td><td colspan="1" rowspan="1">407</td><td colspan="1" rowspan="1">0.94 (0.37–5.2)</td><td colspan="1" rowspan="1">55</td><td colspan="1" rowspan="1">0 (−1–25)</td></tr></tbody></table></div><div id="largeobj_idm139961320339152" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4408440/table/awu405-T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="awu405-TF1"><p id="__p11" class="p p-first-last">PP = primary progressive multiple sclerosis; MSSS = Multiple Sclerosis Severity Score; REP = replication; OCB+ = oligoclonal band positive status, IgG+ = IgG index&gt;0.7.</p></div></div></div></div><div id="__sec4" class="sec"><h3 id="__sec4title">CSF analyses</h3><p id="__p12" class="p p-first-last">All patients included in this study fulfilled Poser or McDonald multiple sclerosis criteria (<a href="#awu405-B36" rid="awu405-B36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165954">Poser <em>et al.</em>, 1983</a>; <a href="#awu405-B27" rid="awu405-B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165958">McDonald <em>et al.</em>, 2001</a>) or were diagnosed as clinically isolated syndrome [<em>n = </em>7 (0.2%) in screening phase (Germany); <em>n = </em>138 (3.5%) in replication phase (Germany)], based on the combination of (i) a clinical symptom being typical and suggestive for multiple sclerosis; (ii) MRI of the brain and in most cases also of the spinal cord demonstrating typical multiple sclerosis lesions fulfilling the criteria of dissemination in space (Barkhof criteria or Swanton criteria); and (iii) CSF parameters. In most countries recruiting samples to this study, lumbar puncture is done routinely as part of the diagnostic process and is seldom repeated unless the diagnosis is unclear. OCB status is considered positive when more than one OCB was seen in the CSF that was not present in the serum. IgG index is considered positive for values &gt;0.7. In this study the IgG index value was used in quantitative trait statistical analyses after transforming the IgG index ratio by taking the logarithm (base 2) (log<sub>2</sub> IgG).</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Clinical analyses</h3><p id="__p13" class="p p-first-last">The clinical parameters gender, age at onset, Multiple Sclerosis Severity Score (<a href="#awu405-B41" rid="awu405-B41" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166010">Roxburgh <em>et al.</em>, 2005</a>), disease course and disease duration at lumbar puncture were included in the clinical analyses. Statistical analyses of CSF phenotypes related to demographic and clinical parameters were done in R 2.14.1 (<a href="http://www.r-project.org" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">www.r-project.org</a>) using linear regression for IgG index and logistic regression for the binary OCB status. We included covariates in the analyses as indicated.</p></div><div id="__sec6" class="sec"><h3 id="__sec6title">Screening phase</h3><p id="__p14" class="p p-first">Quality control and analysis of genetic data provided in the multiple sclerosis genome-wide association study (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165984">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>) were performed with Plink v1.07 (<a href="#awu405-B37" rid="awu405-B37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165999">Purcell <em>et al.</em>, 2007</a>). For OCB status, we used a qualitative trait analysis in a logistic regression with binary outcome (OCB pos/neg). For IgG index, we applied a quantitative trait analysis in a linear regression with allele dosage as independent variable and IgG index as dependent outcome. In the screening phase, gender and the seven main principal components previously determined in this data set (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166051">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>) were associated with IgG index and hence added as covariates for IgG index analyses. Evidence of association was tested in samples from each country individually and combined in a fixed-effects meta-analysis (assuming a qualitative trait for OCB and quantitative trait for IgG) over all countries. <em>P-</em>values &lt; 5 × 10<sup>−8</sup> and &lt;10<sup>−4.5</sup> in the screening phase were considered as genome-wide significant and suggestive evidence, respectively, as applied previously (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166005">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). For each lead SNP a conditional analysis of the surrounding 3 Mb region was performed, and SNPs reaching <em>P</em> &lt; 10<sup>−4</sup> were considered suggestive in this analysis.</p><p id="__p15" class="p p-last">Power for OCB analysis was determined mainly by the typical frequency of OCB-negative status in a multiple sclerosis study population. In the screening phase, we had 80% power to detect suggestive evidence (<em>P</em> &lt; 10<sup>−4.5</sup>) for variants with a minor allele frequency of 0.20 and an odds ratio (OR) of 1.6. Power was 80% for variants explaining 2.5% of the variation in the distribution of IgG index seen in patients with multiple sclerosis.</p></div><div id="__sec7" class="sec"><h3 id="__sec7title">Replication phase</h3><p id="__p16" class="p p-first">Forty-two SNPs were selected for replication. Of these, 38 SNPs were brought forward to replication based on the results from the screening phase; 32 lead SNPs reaching <em>P</em> &lt; 10<sup>−4.5</sup>, an additional proxy marker for rs6457617 (rs9275224 with r<sup>2 </sup>= 1), and five SNPs with conditional association signals of <em>P</em> &lt; 10<sup>−4</sup>. Additionally, we added two SNPs that were previously suggested to be associated with OCB status (<a href="#awu405-B23" rid="awu405-B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165992">Leone <em>et al.</em>, 2013</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165965">Mero <em>et al.</em>, 2013</a>) and two SNPs reported to be associated to autoantibody presence in other tissues (<a href="#awu405-B9" rid="awu405-B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166031">Ferreira <em>et al.</em>, 2010</a>; <a href="#awu405-B35" rid="awu405-B35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166023">Plagnol <em>et al.</em>, 2011</a>) and showing association or a trend for association with IgG index in our study. The SNPs were genotyped using Sequenom MassARRAY® iPLEX® technology (Sequenom Inc.). Sequenom MassARRAY® Designer software v3.1 was used to design primers and extension probes. As part of validating the design, a test set of genotyping data from 86 individuals generated with Illumina platforms was included. Seven SNPs were replaced by proxies with moderate to high linkage disequilibrium (r<sup>2 </sup>&gt; 0.63). For two SNPs, no assay could be designed and for two others genotyping assays failed, therefore a total of 38 SNPs were successfully included in the replication analysis (i.e. 28 lead SNPs and one synonym, five conditional SNPs and four SNPs selected from previous studies) (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary material</a>). Seventy-five nanograms of genomic DNA was used in 5 μl reactions in 384-well plates. The amplified resin-treated DNA was spotted with a Sequenom MassARRAY® Nanodispenser (Sequenom Inc.) on a SpectroCHIP Array. The SpectroCHIP Arrays were analysed using a Sequenom MALDI-TOF mass spectrometer (Sequenom Inc.). Genotyping calls were automatically generated using the MassARRAY® TyperAnalyzer software v4.0 (Sequenom Inc.) and were validated by manual review of the raw mass spectra scatter plots.</p><p id="__p17" class="p p-last">Genotyping quality control was performed in samples grouped per country. Samples with &gt;4/38 missing genotypes (&lt;89.5% sample success rate) and SNPs with &lt;95% genotyping success rate were excluded from further analysis. No SNPs deviated from Hardy-Weinberg equilibrium (<em>P</em> &lt; 10<sup>−4</sup>), except for a known multiple sclerosis susceptibility SNP in the MHC region in the Norwegian population. Analysis was performed per country with a linear model including gender as covariate for IgG and a logistic model for OCB, followed by a fixed-effects meta-analysis over all countries. An effect was considered replicated when reaching <em>P</em> &lt; 0.05 in the replication phase.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Combined analyses</h3><p id="__p18" class="p p-first-last">Analysis was performed by a fixed-effects meta-analysis over all cohorts (screening and replication cohorts per country as described previously). The percentage of the variance in IgG index explained by variants was calculated by subtracting adjusted r<sup>2</sup> from a full model with that from the baseline linear model in R. Evidence for interaction between variants, defined as deviation from a multiplicative model, was investigated in a linear (IgG index) or logistic (OCB status) regression in R.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Major histocompatibility complex analyses</h3><p id="__p19" class="p p-first-last">In the screening phase HLA-A, -B, -C, -DRB1, -DQA1 and -DQB1 genotypes were imputed from SNP data as described previously (<a href="#awu405-B7" rid="awu405-B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166003">Dilthey <em>et al.</em>, 2011</a>; <a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166004">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). The most likely imputed alleles were used as input for testing of association of common HLA alleles with CSF phenotypes using the same regression approach as described for SNPs above. Independent effects of SNPs/haplotypes in the MHC region were investigated with a likelihood ratio test for OCB status or F-test for IgG index comparing a null model and alternative model for phased haplotypes with a minor haplotype frequency of 0.05 including country, seven principal components (screening phase only) and gender as covariates (–chap option in Plink v1.07). The most likely model was obtained by starting with a null model with equal effects for all haplotypes consisting of known and novel replicated MHC signals and allowing separate effects for individual haplotypes, in order of significance, as long as this improved the model with nominal significance.</p></div><div id="__sec10" class="sec sec-last"><h3 id="__sec10title">Multiple sclerosis genetic burden</h3><p id="__p20" class="p p-first-last">In the screening phase, a genetic risk score, multiple sclerosis genetic burden, was calculated on the basis of the number of risk alleles weighted by their effect on multiple sclerosis risk according to the method described previously (<a href="#awu405-B12" rid="awu405-B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166054">Gourraud <em>et al.</em>, 2011</a>; <a href="#awu405-B14" rid="awu405-B14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165989">Harbo <em>et al.</em>, 2014</a>). Two scores were calculated, both including the 57 risk SNPs and either including or excluding alleles imputed as above for the four HLA effects (HLA-DRB1*15:01, DRB1*03:01, DRB1*13:03 and HLA–A*02:01) established in our previous genome-wide association study on susceptibility including this data set (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166001">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). A logistic regression analysis with country as covariate was performed for OCB status, whereas a linear regression analysis including country, gender and seven principal components was performed for IgG index in R.</p></div></div><div id="__sec11" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec11title">Results</h2><div id="__sec12" class="sec sec-first"><h3 id="__sec12title">Clinical and CSF analyses</h3><p id="__p21" class="p p-first">The main demographic and clinical characteristics of patients included in the screening and replication phase, stratified by country of origin, are described in <a href="/pmc/articles/PMC4408440/table/awu405-T1/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T1" rid-ob="ob-awu405-T1" co-legend-rid=""><span>Table 1</span></a>. Among 6868 patients with multiple sclerosis with known OCB status, 6033 (88%) were OCB-positive. The IgG index level in patients recruited from different countries is shown in <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 1</a>. An elevated IgG index was found in 1996 of 3126 patients with known IgG index (64%). IgG index was on average lower in Italian and higher in Danish and Norwegian patients. For 3044 patients, both OCB status and IgG index were available. Increased IgG index was highly correlated with OCB status (<em>P</em> &lt; 2 × 10<sup>−16</sup>) in the combined data set (<a href="/pmc/articles/PMC4408440/table/awu405-T2/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T2" rid-ob="ob-awu405-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 2</a>). Overall, 62% of the patients with multiple sclerosis were positive and 10% were negative for both OCB and IgG index (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 1</a>). On average, 26% of the patients were OCB-positive but did not have an increased IgG index. An increased IgG index in OCB-negative patients with multiple sclerosis was rare (2%).
</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="awu405-T2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p22">Correlation of CSF measures with demographic and clinical variables of the included multiple sclerosis patients</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961284459520" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th colspan="1" rowspan="1"></th><th colspan="3" rowspan="1" align="center">Screening<hr></th><th colspan="3" rowspan="1" align="center">Replication<hr></th><th colspan="3" rowspan="1" align="center">Combined<hr></th></tr><tr><th colspan="1" rowspan="1">Log IgG versus</th><th colspan="1" rowspan="1" align="left"><em>n</em></th><th colspan="1" rowspan="1" align="left">Fold change<sup>e</sup></th><th colspan="1" rowspan="1" align="left"><em>P</em></th><th colspan="1" rowspan="1" align="left"><em>n</em></th><th colspan="1" rowspan="1" align="left">Fold change<sup>e</sup></th><th colspan="1" rowspan="1" align="left"><em>P</em></th><th colspan="1" rowspan="1" align="left"><em>n</em></th><th colspan="1" rowspan="1" align="left">Fold change IgG index (95% CI)<sup>e</sup></th><th colspan="1" rowspan="1" align="left"><em>P</em></th></tr></thead><tbody align="left"><tr><td colspan="1" rowspan="1">Gender (female)<sup>a</sup></td><td colspan="1" rowspan="1">938</td><td colspan="1" rowspan="1">1.136</td><td colspan="1" rowspan="1"><strong>1.4 × 10<sup>−4</sup></strong></td><td colspan="1" rowspan="1">2188</td><td colspan="1" rowspan="1">1.115</td><td colspan="1" rowspan="1"><strong>7.6 × 10<sup>−7</sup></strong></td><td colspan="1" rowspan="1">3126</td><td colspan="1" rowspan="1">1.124 (1.085–1.165)</td><td colspan="1" rowspan="1"><strong>1.9 × 10<sup>−10</sup></strong></td></tr><tr><td colspan="1" rowspan="1">OCB-status (positive)<sup>b</sup></td><td colspan="1" rowspan="1">905</td><td colspan="1" rowspan="1">1.637</td><td colspan="1" rowspan="1"><strong>&lt;2 × 10<sup>−16</sup></strong></td><td colspan="1" rowspan="1">2139</td><td colspan="1" rowspan="1">1.640</td><td colspan="1" rowspan="1"><strong>&lt;2 × 10<sup>−16</sup></strong></td><td colspan="1" rowspan="1">3044</td><td colspan="1" rowspan="1">1.639 (1.559–1.724)</td><td colspan="1" rowspan="1"><strong>&lt;2 × 10<sup>−16</sup></strong></td></tr><tr><td colspan="1" rowspan="1">Age at onset<sup>b</sup></td><td colspan="1" rowspan="1">728</td><td colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1"><strong>0.024</strong></td><td colspan="1" rowspan="1">2110</td><td colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">0.065</td><td colspan="1" rowspan="1">2838</td><td colspan="1" rowspan="1">0.998 (0.996–0.999)</td><td colspan="1" rowspan="1"><strong>0.013</strong></td></tr><tr><td colspan="1" rowspan="1">Disease course (PP)<sup>c</sup></td><td colspan="1" rowspan="1">712</td><td colspan="1" rowspan="1">0.928</td><td colspan="1" rowspan="1">0.27</td><td colspan="1" rowspan="1">2106</td><td colspan="1" rowspan="1">1.031</td><td colspan="1" rowspan="1">0.42</td><td colspan="1" rowspan="1">2818</td><td colspan="1" rowspan="1">1.008 (0.944–1.076)</td><td colspan="1" rowspan="1">0.81</td></tr><tr><td colspan="1" rowspan="1">MSSS<sup>c</sup></td><td colspan="1" rowspan="1">679</td><td colspan="1" rowspan="1">1.021</td><td colspan="1" rowspan="1"><strong>0.0032</strong></td><td colspan="1" rowspan="1">1761</td><td colspan="1" rowspan="1">1.009</td><td colspan="1" rowspan="1">0.064</td><td colspan="1" rowspan="1">2440</td><td colspan="1" rowspan="1">1.014 (1.006–1.021)</td><td colspan="1" rowspan="1"><strong>4.0 × 10<sup>−4</sup></strong></td></tr><tr><td colspan="1" rowspan="1">Disease duration lumbar puncture<sup>d</sup></td><td colspan="1" rowspan="1">707</td><td colspan="1" rowspan="1">1.002</td><td colspan="1" rowspan="1">0.55</td><td colspan="1" rowspan="1">1899</td><td colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">0.35</td><td colspan="1" rowspan="1">2606</td><td colspan="1" rowspan="1">0.999 (0.996–1.002)</td><td colspan="1" rowspan="1">0.65</td></tr><tr><td colspan="10" rowspan="1"><hr></td></tr><tr><td colspan="1" rowspan="1"><strong>OCB-status versus</strong></td><td colspan="1" rowspan="1"><strong><em>n</em></strong></td><td colspan="1" rowspan="1"><strong>OR<sup>f</sup></strong></td><td colspan="1" rowspan="1"><strong><em>P</em></strong></td><td colspan="1" rowspan="1"><strong><em>n</em></strong></td><td colspan="1" rowspan="1"><strong>OR<sup>f</sup></strong></td><td colspan="1" rowspan="1"><strong><em>P</em></strong></td><td colspan="1" rowspan="1"><strong><em>n</em></strong></td><td colspan="1" rowspan="1"><strong>OR OCB pos (95% CI)<sup>f</sup></strong></td><td colspan="1" rowspan="1"><strong><em>P</em></strong></td></tr><tr><td colspan="10" rowspan="1"><hr></td></tr><tr><td colspan="1" rowspan="1">Gender (female)<sup>a</sup></td><td colspan="1" rowspan="1">3026</td><td colspan="1" rowspan="1">1.172</td><td colspan="1" rowspan="1">0.19</td><td colspan="1" rowspan="1">3842</td><td colspan="1" rowspan="1">1.406</td><td colspan="1" rowspan="1"><strong>0.0011</strong></td><td colspan="1" rowspan="1">6868</td><td colspan="1" rowspan="1">1.298 (1.111–1.514)</td><td colspan="1" rowspan="1"><strong>9.7 × 10<sup>−4</sup></strong></td></tr><tr><td colspan="1" rowspan="1">Age at onset<sup>b</sup></td><td colspan="1" rowspan="1">2607</td><td colspan="1" rowspan="1">0.982</td><td colspan="1" rowspan="1"><strong>0.0033</strong></td><td colspan="1" rowspan="1">3753</td><td colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">0.092</td><td colspan="1" rowspan="1">6360</td><td colspan="1" rowspan="1">0.989 (0.982–0.996)</td><td colspan="1" rowspan="1"><strong>0.0028</strong></td></tr><tr><td colspan="1" rowspan="1">Disease course (PP)<sup>c</sup></td><td colspan="1" rowspan="1">2549</td><td colspan="1" rowspan="1">1.066</td><td colspan="1" rowspan="1">0.74</td><td colspan="1" rowspan="1">3715</td><td colspan="1" rowspan="1">0.894</td><td colspan="1" rowspan="1">0.49</td><td colspan="1" rowspan="1">6264</td><td colspan="1" rowspan="1">0.989 (0.782–1.261)</td><td colspan="1" rowspan="1">0.93</td></tr><tr><td colspan="1" rowspan="1">MSSS<sup>c</sup></td><td colspan="1" rowspan="1">1694</td><td colspan="1" rowspan="1">1.040</td><td colspan="1" rowspan="1">0.18</td><td colspan="1" rowspan="1">2401</td><td colspan="1" rowspan="1">1.005</td><td colspan="1" rowspan="1">0.85</td><td colspan="1" rowspan="1">4095</td><td colspan="1" rowspan="1">1.023 (0.987–1.060)</td><td colspan="1" rowspan="1">0.21</td></tr><tr><td colspan="1" rowspan="1">Disease duration lumbar puncture<sup>d</sup></td><td colspan="1" rowspan="1">1343</td><td colspan="1" rowspan="1">1.012</td><td colspan="1" rowspan="1">0.39</td><td colspan="1" rowspan="1">2154</td><td colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">0.81</td><td colspan="1" rowspan="1">3497</td><td colspan="1" rowspan="1">1.003 (0.987–1.020)</td><td colspan="1" rowspan="1">0.71</td></tr></tbody></table></div><div id="largeobj_idm139961284459520" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4408440/table/awu405-T2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="awu405-TF2"><p id="__p23" class="p p-first-last">PP = primary progressive; MSSS = Multiple Sclerosis Severity Score. Covariates included: <sup>a</sup>country; <sup>b</sup>country and gender; <sup>c</sup>country, gender and age at onset; <sup>d</sup>country, gender and age at lumbar puncture (LP). <sup>e</sup>Fold change in IgG index; <sup>f</sup>odds ratio for OCB positivity. Nominally significant <em>P</em>-values are indicated in bold.</p></div></div></div><p id="__p24" class="p p-last">Gender was highly correlated with both IgG index and OCB status. Females had on average a 1.12-fold higher IgG index (<em>P</em> = 1.9 × 10<sup>−10</sup>) and were 1.3-fold more likely to be OCB-positive than males (<em>P</em> = 9.7 × 10<sup>−4</sup>) (<a href="/pmc/articles/PMC4408440/table/awu405-T2/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T2" rid-ob="ob-awu405-T2" co-legend-rid=""><span>Table 2</span></a> and <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 3</a>). There was no correlation either between IgG index or OCB status and the interval between onset and lumbar puncture (median of 1 year). Younger patients had higher IgG indices (<em>P</em> = 0.013), and were more likely to be OCB-positive (<em>P</em> = 0.0028). We found no correlation between multiple sclerosis subtype (bout onset or progressive onset) and IgG index or OCB status after correction for gender and age at onset. Patients with a higher IgG index were more severely affected, as assessed by the Multiple Sclerosis Severity Score (<em>P</em> = 4.0 × 10<sup>−4</sup>).</p></div><div id="__sec13" class="sec"><h3 id="__sec13title">Genome-wide association screen</h3><p id="__p25" class="p p-first">After quality control of the screening data, 485 522 SNPs in 3026 samples and 485 236 SNPs in 938 samples were available for the analysis of OCB status and IgG index, respectively (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 2</a>). Genomic inflation factor was 0.987 for OCB and 1.015 for IgG index (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 4</a>).</p><p id="__p26">We first performed a genome-wide analysis of all SNPs and CSF data available (<a href="/pmc/articles/PMC4408440/figure/awu405-F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="awu405-F1" rid-ob="ob-awu405-F1" co-legend-rid="lgnd_awu405-F1"><span>Fig. 1</span></a>). Markers in the MHC region on chromosome 6 were associated with OCB status with genome-wide significance (<em>P</em> &lt; 5 × 10<sup>−8</sup>). We identified two regions showing genome-wide significance for association based on the IgG index, the MHC region on chromosome 6 and the IGHC region on chromosome 14. In addition, 14 lead SNPs and two conditional SNPs, and 15 lead SNPs and three conditional SNPs reached suggestive evidence for OCB status and IgG index, respectively (<a href="/pmc/articles/PMC4408440/table/awu405-T3/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T3" rid-ob="ob-awu405-T3" co-legend-rid=""><span>Tables 3</span></a> and <a href="/pmc/articles/PMC4408440/table/awu405-T4/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T4" rid-ob="ob-awu405-T4" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and4),</span></span><span>4</span></a>), and were thus taken forward to replication.


</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="awu405-F1" co-legend-rid="lgnd_awu405-F1"><a href="/pmc/articles/PMC4408440/figure/awu405-F1/" target="figure" rid-figpopup="awu405-F1" rid-ob="ob-awu405-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--></a><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961287116752" class="figure"><a href="/pmc/articles/PMC4408440/figure/awu405-F1/" target="figure" rid-figpopup="awu405-F1" rid-ob="ob-awu405-F1"></a><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=4408440_awu405f1p.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.
Object name is awu405f1p.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC4408440/bin/awu405f1p.jpg"></a></div><div id="largeobj_idm139961287116752" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4408440/figure/awu405-F1/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_awu405-F1"><div><a class="figpopup" href="/pmc/articles/PMC4408440/figure/awu405-F1/" target="figure" rid-figpopup="awu405-F1" rid-ob="ob-awu405-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p27"><strong>Manhattan plot of genome-wide association screen for (A) OCB status and (B) IgG index.</strong> Red line indicates genome-wide significance, blue line suggestive evidence.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="awu405-T3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p28">Genetic associations for OCB -positive versus -negative patients with multiple sclerosis</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961316772624" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th colspan="1" rowspan="1"></th><th colspan="1" rowspan="1"></th><th colspan="4" rowspan="1" align="center">Screen (<em>n</em> = 3026)<hr></th><th colspan="3" rowspan="1" align="center">Replication (<em>n</em> = 3478)<hr></th><th colspan="2" rowspan="1" align="center">Combined (<em>n</em> = 6504)<hr></th></tr><tr><th colspan="1" rowspan="1">CHR</th><th colspan="1" rowspan="1">POS</th><th colspan="1" rowspan="1">SNP</th><th colspan="1" rowspan="1">Minor Allele</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">OR</th><th colspan="1" rowspan="1">SNP</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">OR</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">OR (95% CI)</th></tr></thead><tbody align="left"><tr><td colspan="11" rowspan="1"><strong>Primary signals</strong></td></tr><tr><td colspan="1" rowspan="1"><strong>2</strong></td><td colspan="1" rowspan="1">179005067</td><td colspan="1" rowspan="1">rs3997876</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.22 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.65</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">12763938</td><td colspan="1" rowspan="1">rs1467025</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">2.20 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.71</td><td colspan="1" rowspan="1">rs1467025</td><td colspan="1" rowspan="1">0.88</td><td colspan="1" rowspan="1">0.99</td><td colspan="1" rowspan="1">0.0030</td><td colspan="1" rowspan="1">0.85 (0.76–0.95)</td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">53531263</td><td colspan="1" rowspan="1">rs979220</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">3.12 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.69</td><td colspan="1" rowspan="1">rs979220</td><td colspan="1" rowspan="1">0.85</td><td colspan="1" rowspan="1">1.02</td><td colspan="1" rowspan="1">0.0057</td><td colspan="1" rowspan="1">0.84 (0.74–0.95)</td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">109630418</td><td colspan="1" rowspan="1">rs3900940</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.74 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">1.51</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>4</strong></td><td colspan="1" rowspan="1">169864539</td><td colspan="1" rowspan="1">rs9312352</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">3.35 × 10<sup>−7</sup></td><td colspan="1" rowspan="1">0.6</td><td colspan="1" rowspan="1">rs9312352</td><td colspan="1" rowspan="1">0.22</td><td colspan="1" rowspan="1">1.14</td><td colspan="1" rowspan="1">0.0040</td><td colspan="1" rowspan="1">0.81 (0.7–0.93)</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">19718096</td><td colspan="1" rowspan="1">rs9465463</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">5.54 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.57</td><td colspan="1" rowspan="1">rs2743602<sup>a</sup></td><td colspan="1" rowspan="1">0.67</td><td colspan="1" rowspan="1">1.06</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">32700178</td><td colspan="1" rowspan="1">rs9271640</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">6.21 × 10<sup>−10</sup></td><td colspan="1" rowspan="1">1.81</td><td colspan="1" rowspan="1">rs9271640</td><td colspan="1" rowspan="1"><strong>2.15 × 10<sup>−4</sup></strong></td><td colspan="1" rowspan="1">1.38</td><td colspan="1" rowspan="1"><strong>4.91 × 10<sup>−12</sup></strong></td><td colspan="1" rowspan="1">1.56 (1.38–1.77)</td></tr><tr><td colspan="1" rowspan="1"><strong>7</strong></td><td colspan="1" rowspan="1">30113824</td><td colspan="1" rowspan="1">rs12701006</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">7.00 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.55</td><td colspan="1" rowspan="1">rs12701006</td><td colspan="1" rowspan="1">0.89</td><td colspan="1" rowspan="1">0.98</td><td colspan="1" rowspan="1">6.37 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">0.71 (0.58–0.86)</td></tr><tr><td colspan="1" rowspan="1"><strong>7</strong></td><td colspan="1" rowspan="1">40906212</td><td colspan="1" rowspan="1">rs11767956</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.74 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">1.44</td><td colspan="1" rowspan="1">rs11767956</td><td colspan="1" rowspan="1">0.94</td><td colspan="1" rowspan="1">0.99</td><td colspan="1" rowspan="1">0.0050</td><td colspan="1" rowspan="1">1.17 (1.05–1.31)</td></tr><tr><td colspan="1" rowspan="1"><strong>9</strong></td><td colspan="1" rowspan="1">18243014</td><td colspan="1" rowspan="1">rs11790235</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">2.36 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.48</td><td colspan="1" rowspan="1">rs11790235</td><td colspan="1" rowspan="1">0.22</td><td colspan="1" rowspan="1">0.83</td><td colspan="1" rowspan="1">2.44 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.63 (0.51–0.78)</td></tr><tr><td colspan="1" rowspan="1"><strong>10</strong></td><td colspan="1" rowspan="1">34249465</td><td colspan="1" rowspan="1">rs743107</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.78 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.65</td><td colspan="1" rowspan="1">rs743107</td><td colspan="1" rowspan="1">0.5</td><td colspan="1" rowspan="1">0.94</td><td colspan="1" rowspan="1">4.80 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">0.78 (0.68–0.9)</td></tr><tr><td colspan="1" rowspan="1"><strong>10</strong></td><td colspan="1" rowspan="1">71371517</td><td colspan="1" rowspan="1">rs3793821</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.57 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.61</td><td colspan="1" rowspan="1">rs16927103<sup>b</sup></td><td colspan="1" rowspan="1">0.38</td><td colspan="1" rowspan="1">0.91</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>18</strong></td><td colspan="1" rowspan="1">46778159</td><td colspan="1" rowspan="1">rs9807334</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">3.58 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.58</td><td colspan="1" rowspan="1">rs9807334</td><td colspan="1" rowspan="1"><strong>0.02</strong></td><td colspan="1" rowspan="1">0.76</td><td colspan="1" rowspan="1"><strong>8.45 × 10<sup>−7</sup></strong></td><td colspan="1" rowspan="1">0.66 (0.56–0.78)</td></tr><tr><td colspan="1" rowspan="1"><strong>23</strong></td><td colspan="1" rowspan="1">72267781</td><td colspan="1" rowspan="1">rs723923</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.78 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.51</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>23</strong></td><td colspan="1" rowspan="1">142351548</td><td colspan="1" rowspan="1">rs6636962</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.59 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.61</td><td colspan="1" rowspan="1">rs6636962</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">7.01 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">0.78 (0.68–0.9)</td></tr><tr><td colspan="11" rowspan="1"><strong>Conditional signals</strong></td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">108688432</td><td colspan="1" rowspan="1">rs1299704</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">7.14 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.73</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">32601567</td><td colspan="1" rowspan="1">rs34083746</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">4.14 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.61</td><td colspan="1" rowspan="1">rs3957148<sup>c</sup></td><td colspan="1" rowspan="1">0.059</td><td colspan="1" rowspan="1">0.80</td><td colspan="1" rowspan="1">2.38 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">0.73 (0.62–0.86)</td></tr><tr><td colspan="11" rowspan="1"><strong>Previously reported associations</strong></td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">141582383</td><td colspan="1" rowspan="1">rs17411949</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">0.0002</td><td colspan="1" rowspan="1">0.56</td><td colspan="1" rowspan="1">rs17411949</td><td colspan="1" rowspan="1">0.65</td><td colspan="1" rowspan="1">1.08</td><td colspan="1" rowspan="1">0.014</td><td colspan="1" rowspan="1">0.75 (0.6–0.94)</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">98125801</td><td colspan="1" rowspan="1">rs9320598</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">0.00298</td><td colspan="1" rowspan="1">0.63</td><td colspan="1" rowspan="1">rs9489141<sup>d</sup></td><td colspan="1" rowspan="1">0.23</td><td colspan="1" rowspan="1">0.84</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr></tbody></table></div><div id="largeobj_idm139961316772624" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4408440/table/awu405-T3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="awu405-TF3"><p id="__p29" class="p p-first-last">Correlation between replication and screen SNPs: <sup>a</sup>r<sup>2 </sup>= 1; <sup>b</sup>r<sup>2 </sup>= 0.79; <sup>c</sup>r<sup>2 </sup>= 0.63; <sup>d</sup>r<sup>2 </sup>= 1. CHR = chromosome; POS = position (hg18). Signals meeting criteria for replication are indicated in bold.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="awu405-T4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p30">Genetic associations for IgG index in patients with multiple sclerosis.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961320205296" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead align="left"><tr><th colspan="1" rowspan="1"></th><th colspan="1" rowspan="1"></th><th colspan="4" rowspan="1" align="center">Screen (<em>n = </em>938)<hr></th><th colspan="3" rowspan="1" align="center">Replication (<em>n = </em>2072)<hr></th><th colspan="2" rowspan="1" align="center">Combined (<em>n = </em>3010)<hr></th></tr><tr><th colspan="1" rowspan="1">CHR</th><th colspan="1" rowspan="1">POS</th><th colspan="1" rowspan="1">SNP</th><th colspan="1" rowspan="1">Minor allele</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">Beta log IgG index</th><th colspan="1" rowspan="1">SNP</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">Beta log IgG index</th><th colspan="1" rowspan="1"><em>P</em></th><th colspan="1" rowspan="1">Fold change IgG index (95% CI)</th></tr></thead><tbody align="left"><tr><td colspan="11" rowspan="1"><strong>Primary signals</strong></td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">65383112</td><td colspan="1" rowspan="1">rs12493497</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">1.16 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.138</td><td colspan="1" rowspan="1">rs12493497</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">0.018</td><td colspan="1" rowspan="1">0.0015</td><td colspan="1" rowspan="1">1.04 (1.02–1.07)</td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">115661169</td><td colspan="1" rowspan="1">rs10934275</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">2.68 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">−0.179</td><td colspan="1" rowspan="1">rs10934275</td><td colspan="1" rowspan="1">0.35</td><td colspan="1" rowspan="1">−0.028</td><td colspan="1" rowspan="1">0.0014</td><td colspan="1" rowspan="1">0.95 (0.92–0.98)</td></tr><tr><td colspan="1" rowspan="1"><strong>4</strong></td><td colspan="1" rowspan="1">26927863</td><td colspan="1" rowspan="1">rs4692195</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">2.52 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">−0.151</td><td colspan="1" rowspan="1">rs4692195</td><td colspan="1" rowspan="1">0.73</td><td colspan="1" rowspan="1">−0.008</td><td colspan="1" rowspan="1">0.0080</td><td colspan="1" rowspan="1">0.96 (0.94–0.99)</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">32771829</td><td colspan="1" rowspan="1">rs6457617</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.07 × 10<sup>−10</sup></td><td colspan="1" rowspan="1">−0.206</td><td colspan="1" rowspan="1">rs6457617</td><td colspan="1" rowspan="1"><strong>1.29 × 10<sup>−8</sup></strong></td><td colspan="1" rowspan="1">−0.127</td><td colspan="1" rowspan="1"><strong>6.72 × 10<sup>−17</sup></strong></td><td colspan="1" rowspan="1">0.90 (0.88–0.92)</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">125378498</td><td colspan="1" rowspan="1">rs1413598</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.15 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.151</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1" align="center">NA</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>7</strong></td><td colspan="1" rowspan="1">56016231</td><td colspan="1" rowspan="1">rs3816089</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">2.54 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.264</td><td colspan="1" rowspan="1">rs3816089</td><td colspan="1" rowspan="1">0.91</td><td colspan="1" rowspan="1">0.005</td><td colspan="1" rowspan="1">0.012</td><td colspan="1" rowspan="1">1.06 (1.01–1.12)</td></tr><tr><td colspan="1" rowspan="1"><strong>9</strong></td><td colspan="1" rowspan="1">77456395</td><td colspan="1" rowspan="1">rs1328565</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.22 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.198</td><td colspan="1" rowspan="1">rs1328565</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">−0.003</td><td colspan="1" rowspan="1">0.018</td><td colspan="1" rowspan="1">1.04 (1.01–1.08)</td></tr><tr><td colspan="1" rowspan="1"><strong>10</strong></td><td colspan="1" rowspan="1">95961456</td><td colspan="1" rowspan="1">rs12769135</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">2.72 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">−0.148</td><td colspan="1" rowspan="1">rs12769135</td><td colspan="1" rowspan="1">0.32</td><td colspan="1" rowspan="1">0.024</td><td colspan="1" rowspan="1">0.13</td><td colspan="1" rowspan="1">0.98 (0.95–1.01)</td></tr><tr><td colspan="1" rowspan="1"><strong>10</strong></td><td colspan="1" rowspan="1">132158923</td><td colspan="1" rowspan="1">rs448669</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">2.00 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.186</td><td colspan="1" rowspan="1">rs448669</td><td colspan="1" rowspan="1">0.25</td><td colspan="1" rowspan="1">−0.033</td><td colspan="1" rowspan="1">0.17</td><td colspan="1" rowspan="1">1.02 (0.99–1.06)</td></tr><tr><td colspan="1" rowspan="1"><strong>12</strong></td><td colspan="1" rowspan="1">120146349</td><td colspan="1" rowspan="1">rs3887080</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">2.24 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.2</td><td colspan="1" rowspan="1">rs3887080</td><td colspan="1" rowspan="1">0.10</td><td colspan="1" rowspan="1">0.054</td><td colspan="1" rowspan="1">1.60 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">1.07 (1.03–1.11)</td></tr><tr><td colspan="1" rowspan="1"><strong>13</strong></td><td colspan="1" rowspan="1">26015959</td><td colspan="1" rowspan="1">rs10507368</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">8.63 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">−0.163</td><td colspan="1" rowspan="1">rs10507368</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">0.002</td><td colspan="1" rowspan="1">0.020</td><td colspan="1" rowspan="1">0.97 (0.94–1.00)</td></tr><tr><td colspan="1" rowspan="1"><strong>13</strong></td><td colspan="1" rowspan="1">86546361</td><td colspan="1" rowspan="1">rs9516451</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">5.55 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.284</td><td colspan="1" rowspan="1">rs9516451</td><td colspan="1" rowspan="1">0.34</td><td colspan="1" rowspan="1">−0.040</td><td colspan="1" rowspan="1">0.086</td><td colspan="1" rowspan="1">1.04 (0.99–1.09)</td></tr><tr><td colspan="1" rowspan="1"><strong>14</strong></td><td colspan="1" rowspan="1">99354933</td><td colspan="1" rowspan="1">rs4905899</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.92 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">−0.134</td><td colspan="1" rowspan="1">rs4905899</td><td colspan="1" rowspan="1">0.35</td><td colspan="1" rowspan="1">−0.020</td><td colspan="1" rowspan="1">0.0015</td><td colspan="1" rowspan="1">0.96 (0.94–0.99)</td></tr><tr><td colspan="1" rowspan="1"><strong>14</strong></td><td colspan="1" rowspan="1">105243925</td><td colspan="1" rowspan="1">rs11621145</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">1.48 × 10<sup>−14</sup></td><td colspan="1" rowspan="1">0.263</td><td colspan="1" rowspan="1">rs11621145</td><td colspan="1" rowspan="1"><strong>1.97 × 10<sup>−24</sup></strong></td><td colspan="1" rowspan="1">0.23</td><td colspan="1" rowspan="1"><strong>3.79 × 10<sup>−37</sup></strong></td><td colspan="1" rowspan="1">1.18 (1.13–1.22)</td></tr><tr><td colspan="1" rowspan="1"><strong>16</strong></td><td colspan="1" rowspan="1">75867997</td><td colspan="1" rowspan="1">rs2343047</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">2.72 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">−0.151</td><td colspan="1" rowspan="1">rs1594049<sup>a</sup></td><td colspan="1" rowspan="1">0.23</td><td colspan="1" rowspan="1">−0.026</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr><tr><td colspan="1" rowspan="1"><strong>17</strong></td><td colspan="1" rowspan="1">9982874</td><td colspan="1" rowspan="1">rs12162156</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">1.69 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.15</td><td colspan="1" rowspan="1">rs12162156</td><td colspan="1" rowspan="1">0.54</td><td colspan="1" rowspan="1">0.014</td><td colspan="1" rowspan="1">0.0040</td><td colspan="1" rowspan="1">1.04 (1.01–1.07)</td></tr><tr><td colspan="1" rowspan="1"><strong>22</strong></td><td colspan="1" rowspan="1">24768495</td><td colspan="1" rowspan="1">rs6004913</td><td colspan="1" rowspan="1">G</td><td colspan="1" rowspan="1">3.48 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.183</td><td colspan="1" rowspan="1">rs6004913</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">0.002</td><td colspan="1" rowspan="1">0.0066</td><td colspan="1" rowspan="1">1.04 (1.01–1.08)</td></tr><tr><td colspan="11" rowspan="1"><strong>Conditional signals</strong></td></tr><tr><td colspan="1" rowspan="1"><strong>3</strong></td><td colspan="1" rowspan="1">117229505</td><td colspan="1" rowspan="1">rs9289038</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">0.0001</td><td colspan="1" rowspan="1">−0.145</td><td colspan="1" rowspan="1">rs9289038</td><td colspan="1" rowspan="1">0.28</td><td colspan="1" rowspan="1">0.0337</td><td colspan="1" rowspan="1">0.10</td><td colspan="1" rowspan="1">0.97 (0.94–1.01)</td></tr><tr><td colspan="1" rowspan="1"><strong>6</strong></td><td colspan="1" rowspan="1">30183822</td><td colspan="1" rowspan="1">rs3132679</td><td colspan="1" rowspan="1">A</td><td colspan="1" rowspan="1">6.61 × 10<sup>−5</sup></td><td colspan="1" rowspan="1">0.151</td><td colspan="1" rowspan="1">rs3132679</td><td colspan="1" rowspan="1">0.10</td><td colspan="1" rowspan="1">0.0444</td><td colspan="1" rowspan="1">2.60 × 10<sup>−4</sup></td><td colspan="1" rowspan="1">1.06 (1.03–1.09)</td></tr><tr><td colspan="1" rowspan="1"><strong>7</strong></td><td colspan="1" rowspan="1">56540030</td><td colspan="1" rowspan="1">rs10249528</td><td colspan="1" rowspan="1">C</td><td colspan="1" rowspan="1">5.02 × 10<sup>−6</sup></td><td colspan="1" rowspan="1">0.158</td><td colspan="1" rowspan="1">rs10256440<sup>b</sup></td><td colspan="1" rowspan="1">0.21</td><td colspan="1" rowspan="1">−0.0303</td><td colspan="1" rowspan="1">NA</td><td colspan="1" rowspan="1">NA</td></tr></tbody></table></div><div id="largeobj_idm139961320205296" class="largeobj-link align_right" style=""><a target="object" href="/pmc/articles/PMC4408440/table/awu405-T4/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="awu405-TF4"><p id="__p31" class="p p-first-last">Correlation between replication and screen SNPs: <sup>a</sup>r<sup>2 </sup>= 0.97; <sup>b</sup>r<sup>2 </sup>= 1. Covariates: gender and seven principal components in screening phase, gender in replication phase. CHR = chromosome; POS = position (hg18). Signals meeting criteria for replication are indicated in bold.</p></div></div></div><p id="__p32">When analysing the 57 multiple sclerosis risk SNPs previously identified in the genome-wide association study (<a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165962">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>) (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 3</a>), one SNP (rs12368653) showed nominally significant association with OCB positivity. For IgG index, 7 of these 57 SNPs (12%) reached nominal significance. The multiple sclerosis associated risk allele increased the IgG index for five of these SNPs. As the contribution to the overall multiple sclerosis risk of each of these SNPs is small, we also estimated the multiple sclerosis genetic burden. This genetic risk score was composed of 57 established non-HLA multiple sclerosis risk SNPs and four classical HLA alleles (<a href="#awu405-B12" rid="awu405-B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165975">Gourraud <em>et al.</em>, 2011</a>; <a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165956">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). A higher multiple sclerosis genetic burden including the HLA alleles was associated with increased IgG index {fold change = 1.11 [95% confidence interval (CI): 1.07–1.15], <em>P</em> = 1.33 × 10<sup>−9</sup>} and OCB status [OR = 1.51 (95% CI: 1.32–1.74), <em>P</em> = 3.44 × 10<sup>−9</sup>], whereas these associations were substantially reduced when considering only non-HLA risk SNPs [IgG index: fold change = 1.06 (95% CI: 1.00–1.13), <em>P</em> = 0.038; OCB: OR = 1.19 (95% CI: 0.96–1.48), <em>P</em> = 0.12], indicating the MHC region as the main contributor.</p><p id="__p33" class="p p-last">Subsequently, we investigated SNPs known from the literature to be associated with the presence of antibodies in diverse other tissues (Pubmed and Catalogue of Genome-wide Association Studies 4/12/2012) (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 4</a>). A SNP tagging HLA-DRB1*15:01 (rs3129934), which is reported to be protective against IgA deficiency, increased IgG index (<em>P</em> = 1.37 × 10<sup>−7</sup>) as well as the risk of OCB positivity in multiple sclerosis (<em>P</em> = 3.7 × 10<sup>−4</sup>).</p></div><div id="__sec14" class="sec"><h3 id="__sec14title">Replication</h3><p id="__p34" class="p p-first-last">A total of 42 SNPs were taken forward to the replication phase and 38 SNPs were successfully genotyped (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 5</a>). After quality control (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 6</a>), 3478 patients with OCB status and 2072 with IgG index data available were analysed. The same two regions that were associated with genome-wide significance with IgG index in the screening phase, i.e. the MHC and IGHC region, reached genome-wide significance in the replication phase as well (<a href="/pmc/articles/PMC4408440/table/awu405-T3/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T3" rid-ob="ob-awu405-T3" co-legend-rid=""><span>Tables 3</span></a> and <a href="/pmc/articles/PMC4408440/table/awu405-T4/" target="table" class="fig-table-link figpopup" rid-figpopup="awu405-T4" rid-ob="ob-awu405-T4" co-legend-rid=""><span style="position: relative;text-decoration:none;">​<span class="figpopup-sensitive-area" style="left: -1.5em;">and4).</span></span><span>4</span></a>). One novel non-MHC region (rs9807334 near <em>ELAC1</em>/S<em>MAD4</em>) was replicated with nominal significance for association with OCB status.</p></div><div id="__sec15" class="sec sec-last"><h3 id="__sec15title">Combined analyses</h3><p id="__p35" class="p p-first">Given the highly significant correlation between OCB status and IgG index, we compared results from a detailed analysis of the MHC class II region for both characteristics (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Table 7</a> and <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Fig. 2</a>). The most likely model in the combined analysis included two independent effects in the MHC class II region on OCB status; a major effect of the rs9271640*A-rs6457617*G haplotype and an additional effect of rs3957148 (tagging SNP with r<sup>2 </sup>= 0.63 for rs34083746 identified in the screening phase). The first signal is highly correlated with the HLA-DRB1*1501 haplotype (r<sup>2 </sup>= 0.94), whereas the second is strongly correlated with HLA-DQA1*0301 (rs34083746: r<sup>2 </sup>= 0.93, rs3957148: r<sup>2 </sup>= 0.64), and more modestly with both HLA-DRB1*0401 (rs34083746: r<sup>2 </sup>= 0.39) and *0404 (rs34083746: r<sup>2 </sup>= 0.26). Carrying the MHC SNP allele associated with OCB-positive status at these loci, was associated with a 2-fold higher likelihood of being OCB-positive than carrying the allele associated with OCB-negative status at all three loci [OR = 2.25 (95% CI: 1.84–2.75), <em>P</em> = 8.88 × 10<sup>−16</sup>] (<a href="/pmc/articles/PMC4408440/figure/awu405-F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="awu405-F2" rid-ob="ob-awu405-F2" co-legend-rid="lgnd_awu405-F2"><span>Fig. 2</span></a>A). The rs9271640*A-rs6457617*G haplotype, correlated with DRB1*1501, was associated not only with OCB status, but also IgG index (<em>P</em> = 1.59 × 10<sup>−22</sup>) (<a href="/pmc/articles/PMC4408440/figure/awu405-F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="awu405-F2" rid-ob="ob-awu405-F2" co-legend-rid="lgnd_awu405-F2"><span>Fig. 2</span></a>B). Independent of this haplotype, rs6457617*G had an additional effect increasing IgG index (<em>P</em> = 3.68 × 10<sup>−6</sup>). Notably, the association of rs6457617 with IgG index was observed in both OCB-positive (<em>P</em> = 4.22 × 10<sup>−10</sup>) and OCB-negative multiple sclerosis patients (<em>P</em> = 6.12 × 10<sup>−4</sup>). SNP rs6457617 is only modestly associated with any classical HLA allele (r<sup>2 </sup>&lt; 0.30). SNP rs34083746/rs3957148, correlated with DQA1*0301 and associated with OCB negative status, did not seem to influence IgG index levels. No interaction amongst the associated SNPs in the MHC region or between these and the SNP in the IGHC region was observed (data not shown).
</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="awu405-F2" co-legend-rid="lgnd_awu405-F2"><a href="/pmc/articles/PMC4408440/figure/awu405-F2/" target="figure" rid-figpopup="awu405-F2" rid-ob="ob-awu405-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139961285156688" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.
Object name is awu405f2p.jpg" title="An external file that holds a picture, illustration, etc.
Object name is awu405f2p.jpg" src="/pmc/articles/PMC4408440/bin/awu405f2p.jpg"></div></a><div id="largeobj_idm139961285156688" class="largeobj-link align_right" style="display: none"><a href="/pmc/articles/PMC4408440/figure/awu405-F2/" target="figure" rid-figpopup="awu405-F2" rid-ob="ob-awu405-F2"></a><a target="object" href="/pmc/articles/PMC4408440/figure/awu405-F2/?report=objectonly">Open in a separate window</a></div><div class="icnblk_cntnt" id="lgnd_awu405-F2"><div><a class="figpopup" href="/pmc/articles/PMC4408440/figure/awu405-F2/" target="figure" rid-figpopup="awu405-F2" rid-ob="ob-awu405-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p36"><strong>Most likely model for MHC class II haplotypes (composed of SNPs rs9271640-rs6457617-rs3957148) and CSF phenotype in the combined analysis.</strong> (<strong>A</strong>) OCB status and (<strong>B</strong>) IgG index. GAG haplotype is correlated with HLA-DQA1*0301 (r<sup>2 </sup>= 0.64), AGA haplotype with HLA-DRB1*1501 (r<sup>2 </sup>= 0.94). <em>P-</em>values are given compared to reference haplotypes.</p></div></div></div><p id="__p37">The previously reported association of IgG index with SNPs in the IGHC region was replicated as highly significant in the combined data set (<em>P</em> = 3.79 × 10<sup>−37</sup>) and explains 4.7% of the variance in IgG index in the entire data set. The MHC and IGHC region, the major determinants of variation in IgG index, together explain 7.75% of variance and combined with gender and country, account for 12.65% of variance in IgG index throughout Europe. Forest plots for all association signals per country are given in <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Figs 5</a> and <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">6</a>.</p><p id="__p38" class="p p-last">We also investigated the correlation between the main four established genetic effects and age at onset, disease course and Multiple Sclerosis Severity Score with covariates gender and, for the latter two, age at onset. After correcting for multiple testing, the A-allele of rs9271640 (that was associated with increased IgG levels and likelihood of OCB-positive status), was associated with lower age at onset (<em>P</em><sub>screen</sub><em> = </em>4.44 × 10<sup>−4</sup>, <em>P</em><sub>replicatio</sub><sub>n</sub> = 0.082, <em>P</em><sub>combined</sub> = 5.68 × 10<sup>−4</sup>). In contrast, at the IGHC locus, the allele that increased IgG index showed association with a later age at onset (<em>P</em><sub>screen</sub><em> = </em>0.011, <em>P</em><sub>replication</sub><em> = </em>0.0066, <em>P</em><sub>combined</sub> = 8.23 × 10<sup>−5</sup>) (<a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary Fig. 7</a>).</p></div></div><div id="__sec16" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec16title">Discussion</h2><p id="__p39" class="p p-first">This study is the largest to date that investigates genetic differences, clinical and demographic characteristics in relation to OCB status (<em>n = </em>6868) and IgG index (<em>n = </em>3126) in multiple sclerosis. Our findings strongly support that multiple sclerosis patients with and without OCBs and/or increased IgG index are genetically distinct. This has previously been suggested in other, smaller studies (<a href="#awu405-B21" rid="awu405-B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166047">Kikuchi <em>et al.</em>, 2003</a>; <a href="#awu405-B18" rid="awu405-B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166012">Imrell <em>et al.</em>, 2006</a>; <a href="#awu405-B17" rid="awu405-B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166014">Idiman <em>et al.</em>, 2009</a>; <a href="#awu405-B50" rid="awu405-B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166032">Wu <em>et al.</em>, 2009</a>; <a href="#awu405-B40" rid="awu405-B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165996">Romero-Pinel <em>et al.</em>, 2011</a>; <a href="#awu405-B3" rid="awu405-B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165960">Buck <em>et al.</em>, 2012</a>; <a href="#awu405-B23" rid="awu405-B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165972">Leone <em>et al.</em>, 2013</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166006">Mero <em>et al.</em>, 2013</a>; <a href="#awu405-B51" rid="awu405-B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166009">Yoshimura <em>et al.</em>, 2014</a>) and is now confirmed. In accordance with our previous observations and those of others (<a href="#awu405-B22" rid="awu405-B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166033">Lechner-Scott <em>et al.</em>, 2011</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166028">Mero <em>et al.</em>, 2013</a>; <a href="#awu405-B44" rid="awu405-B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165982">Stangel <em>et al.</em>, 2013</a>), patients with multiple sclerosis and high CSF antibody levels, as characterized by OCB-positive status and/or high IgG index, more often are female and seem to have a lower age at onset and higher Multiple Sclerosis Severity Score. We find that the two CSF parameters included in this study, OCB status and IgG index, are highly correlated (<a href="#awu405-B26" rid="awu405-B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165987">Mayringer <em>et al.</em>, 2005</a>; <a href="#awu405-B24" rid="awu405-B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166029">Link and Huang, 2006</a>; <a href="#awu405-B39" rid="awu405-B39" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166044">Rinker <em>et al.</em>, 2007</a>), supporting that these measurements reflect the same immunological process.</p><p id="__p40">Recently, the IGHC locus on chromosome 14 was reported to be associated with IgG index in German and Belgian patients with multiple sclerosis (<a href="#awu405-B3" rid="awu405-B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166026">Buck <em>et al.</em>, 2012</a>). This is convincingly replicated in the present extended study with the finding of a strong association of rs11621145 to IgG index (<em>P</em><sub>combined</sub> = 3.79 × 10<sup>−37</sup>). In addition, we identify two novel association signals in the MHC region as major genetic determinants for IgG index; rs9271640, which is correlated with the HLA-DRB1*15:01 allele, and rs6457617, which is located near the HLA-DQA1 gene but not known to tag any conventional HLA-allele. An interaction between HLA and IGHC has been suggested (<a href="#awu405-B33" rid="awu405-B33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166055">Pandey, 2013</a>); however, we do not find any evidence to support this hypothesis. Together, these three SNPs from the MHC and IGHC regions explain ∼7.75% of the variance in IgG index.</p><p id="__p41">Several studies have suggested that OCB-positive and -negative patients with multiple sclerosis are associated with different HLA-DRB1 alleles (<a href="#awu405-B21" rid="awu405-B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166052">Kikuchi <em>et al.</em>, 2003</a>; <a href="#awu405-B18" rid="awu405-B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165981">Imrell <em>et al.</em>, 2006</a>; <a href="#awu405-B17" rid="awu405-B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166046">Idiman <em>et al.</em>, 2009</a>; <a href="#awu405-B50" rid="awu405-B50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166025">Wu <em>et al.</em>, 2009</a>; <a href="#awu405-B40" rid="awu405-B40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165991">Romero-Pinel <em>et al.</em>, 2011</a>; <a href="#awu405-B23" rid="awu405-B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166024">Leone <em>et al.</em>, 2013</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165967">Mero <em>et al.</em>, 2013</a>; <a href="#awu405-B51" rid="awu405-B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165961">Yoshimura <em>et al.</em>, 2014</a>). We observe a significant association of SNP rs9271640 tagging HLA-DRB1*15:01 with OCB status and a high correlation of the multiple sclerosis genetic burden including HLA risk alleles with OCB status. Our findings hence support previous observations of the major established multiple sclerosis risk allele, HLA-DRB1*15:01, being more strongly associated with OCB-positive multiple sclerosis than OCB-negative multiple sclerosis. The present study also detects a significant difference between OCB-positive and -negative patients with regard to rs34083746. This SNP is highly correlated with the DQA1*0301 allele shared between DRB1*04 haplotypes. Hence, our findings are consistent with several HLA-DRB1*04 alleles having been shown to increase risk for OCB-negative multiple sclerosis, but not OCB-positive multiple sclerosis, in previous studies from Europe and Japan (<a href="#awu405-B21" rid="awu405-B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165998">Kikuchi <em>et al.</em>, 2003</a>; <a href="#awu405-B18" rid="awu405-B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165979">Imrell <em>et al.</em>, 2006</a>; <a href="#awu405-B29" rid="awu405-B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166048">Mero <em>et al.</em>, 2013</a>; <a href="#awu405-B51" rid="awu405-B51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165974">Yoshimura <em>et al.</em>, 2014</a>). The combination of variation in the MHC region has a major impact on the OCB status of patients with multiple sclerosis, resulting in a &gt;2-fold difference in the odds of being OCB-positive. In addition to replicating previously suggested associations to OCB status within the MHC region, our analyses provide evidence for a novel locus to be associated with OCB status, rs9807334 near the <em>ELAC1</em>/<em>SMAD4</em> genes. The <em>SMAD4</em> gene, a signal transduction protein in the tumor growth factor beta pathway, has previously been implicated in class switch recombination and in experimental autoimmune encephalomyelitis and multiple sclerosis (<a href="#awu405-B34" rid="awu405-B34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166034">Park <em>et al.</em>, 2005</a>; <a href="#awu405-B28" rid="awu405-B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_559348516">Meoli <em>et al.</em>, 2010</a>; <a href="#awu405-B16" rid="awu405-B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166053">Huss <em>et al.</em>, 2011</a>) and the same allele has previously been suggested as associated with vaccine response (<a href="#awu405-B32" rid="awu405-B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165990">Ovsyannikova <em>et al.</em>, 2012</a>).</p><p id="__p42">The CSF phenotype association signals in the MHC region we observe have been associated with susceptibility and antibody levels in other diseases. The HLA-DRB1*1501-DQB1*0601 haplotype has been associated with either the presence or increased quantity of immunoglobulins of the IgG, IgA and IgM families both in healthy controls and in disease, including total immunoglobulins (<a href="#awu405-B9" rid="awu405-B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166007">Ferreira <em>et al.</em>, 2010</a>), antibodies induced by viruses such as Epstein-Barr virus (<a href="#awu405-B42" rid="awu405-B42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165988">Rubicz <em>et al.</em>, 2013</a>), and autoantibodies in type 1 diabetes (<a href="#awu405-B19" rid="awu405-B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166045">Ishii <em>et al.</em>, 2005</a>) and Sjögren syndrome (<a href="#awu405-B11" rid="awu405-B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165986">Gottenberg <em>et al.</em>, 2003</a>) though an opposite correlation is seen for few other antibody responses (<a href="#awu405-B45" rid="awu405-B45" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166000">Sundqvist <em>et al.</em>, 2014</a>). HLA-DQA1*0301, highly correlated with SNP rs34083746, is associated with autoantibody negative disease in ketosis-prone diabetes (<a href="#awu405-B30" rid="awu405-B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165976">Oak <em>et al.</em>, 2014</a>). SNP rs6457617 is a major susceptibility factor in rheumatoid arthritis and systemic sclerosis, independent of classical HLA alleles (<a href="#awu405-B46" rid="awu405-B46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165957">The International MHC and Autoimmunity Genetics Network, 2009</a>; <a href="#awu405-B38" rid="awu405-B38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166036">Radstake <em>et al.</em>, 2010</a>; <a href="#awu405-B1" rid="awu405-B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165968">Allanore <em>et al.</em>, 2011</a>; <a href="#awu405-B31" rid="awu405-B31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166040">Orozco <em>et al.</em>, 2014</a>). Of note, the risk allele for these autoimmune diseases decreases the IgG levels in multiple sclerosis. The IGHC locus, on the other hand, has not been associated with antibody levels in other diseases as yet. Overall, the MHC region may enhance antibody production and OCB-positive status, whereas the IGHC region has been proposed to influence clearance of antibodies from the CSF and hence immunoglobulin levels (<a href="#awu405-B3" rid="awu405-B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165971">Buck <em>et al.</em>, 2012</a>).</p><p id="__p43">Other studies have shown that IgG levels correlate with the number of B cells, more particularly the number of plasmablasts, in the CSF (<a href="#awu405-B43" rid="awu405-B43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165980">Rudick <em>et al.</em>, 1999</a>; <a href="#awu405-B4" rid="awu405-B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165978">Cepok <em>et al.</em>, 2001</a>, <a href="#awu405-B5" rid="awu405-B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166035">2005</a>). B cell follicles in the meninges have been found in a subset of patients with multiple sclerosis and are suggested to play a pathogenic role (<a href="#awu405-B25" rid="awu405-B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165955">Magliozzi <em>et al.</em>, 2007</a>). Moreover, a prognostic potential of findings in the CSF has been proposed, as positivity for OCB is reported to double the risk of developing clinically definite multiple sclerosis in patients with clinically isolated syndrome (<a href="#awu405-B49" rid="awu405-B49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165964">Tintore <em>et al.</em>, 2008</a>). Also, some studies suggest that the inflammation in the brain reflected by CSF alterations may correlate with neurodegeneration and disease progression (<a href="#awu405-B44" rid="awu405-B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166016">Stangel <em>et al.</em>, 2013</a>). Our findings of a lower age at onset and a higher Multiple Sclerosis Severity Score in the patients with multiple sclerosis with marked CSF antibody levels support this hypothesis. In our study, HLA-DRB1*15:01 increases CSF antibody levels and lowers age at onset, as reported previously (<a href="#awu405-B15" rid="awu405-B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166041">Hensiek <em>et al.</em>, 2002</a>; <a href="#awu405-B48" rid="awu405-B48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165993">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2, 2011</a>). However, at the IGHC locus, the allele increasing IgG index seems correlated with higher age at onset, indicating that the mechanisms underlying the correlation between genetic determinants, CSF antibody levels and clinical outcome are not fully understood as yet.</p><p id="__p44">The present study is well-powered, and the clinical characteristics of the patients included support that they are representative of patients with multiple sclerosis in general. On average, OCB positivity was found in 88% and an elevated IgG index in 64% of patients, in accordance with earlier studies (<a href="#awu405-B8" rid="awu405-B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166008">Dobson <em>et al.</em>, 2013</a>; <a href="#awu405-B44" rid="awu405-B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445166049">Stangel <em>et al.</em>, 2013</a>). Lumbar puncture is routinely performed as a part of the diagnostic process in most of the countries included, but a possible selection bias must be kept in mind when interpreting the clinical findings. OCBs and/or increased IgG index in the CSF are clinically important hallmarks in multiple sclerosis, and in this large study we show that these disease phenotypes are associated with both genetic variants and clinical and demographic characteristics. The presence of intrathecal immunoglobulin M has been reported as an additional CSF characteristic in multiple sclerosis patients that may be associated with unfavourable outcome or aggressive disease (<a href="#awu405-B44" rid="awu405-B44" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_445165963">Stangel <em>et al.</em>, 2013</a>). The study of genetic factors underlying immunoglobulin M levels is currently hampered by the availability of data but will be of future interest.</p><p id="__p45" class="p p-last">In summary, in this large study including 6950 patients with multiple sclerosis, we confirm that genetic variants in the immunologically important regions of MHC and IGHC influence OCB status and IgG index in patients with multiple sclerosis.</p></div><div id="idm139961279385136" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139961279385136title">Acknowledgements</h2><div class="sec"><p id="__p46">We thank the patients who participated in this study. We acknowledge the International Multiple Sclerosis Genetics Consortium (IMSGC) and Wellcome Trust Case Control Consortium 2 (WTCCC2) for the collaboration with the establishment of the genotypes that were included in the screening phase of this project. Please see <a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary material</a> for the IMSGC membership list. We thank Leentje Cosemans and the Genomics Core Facility at the KU Leuven (Belgium) for technical assistance with the replication phase and Prof. Koen Poesen for advice. From Norway we thank collaborators from the Multiple Sclerosis Research group in Oslo, especially Anja Bjølgerud and Inger-Lise Mero, and the Norwegian Multiple Sclerosis Register and Biobank for contribution with samples and data. The Italian group thanks the PROGEMUS (PROgnostic GEnetic factors in MUltiple Sclerosis) Consortium, the PROGRESSO Consortium, Dr Mariaemma Rodegher, Dr Lucia Moiola, Dr Bruno Colombo, Dr Vittorio Martinelli, Dr ssa Gabriella Passerini and Prof. Giancarlo Comi. The German group gratefully acknowledges Verena Grummel for her continuous contributions to the DNA biobank. From Australia, Prof. William Carroll, Dr Marzena Fabis-Pedrini, Mr Sean Burnard and Mrs Malgorzata Krupa are thanked for their contributions.</p></div></div><div id="idm139961280744496" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139961280744496title">Glossary</h2><div class="bk-sec"><div><h4>Abbreviations</h4><table class="default-table glossary"><tbody><tr><td id="G2">HLA</td><td>human leukocyte antigen</td></tr><tr><td id="G3">IgG</td><td>immunoglobulin G</td></tr><tr><td id="G4">IGHC</td><td>immunoglobulin heavy chain</td></tr><tr><td id="G5">MHC</td><td>major histocompatibility complex</td></tr><tr><td id="G6">OCB</td><td>oligoclonal band</td></tr><tr><td id="G7">SNP</td><td>single nucleotide polymorphism</td></tr></tbody></table></div></div></div><div id="__sec17" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec17title">Funding</h2><!--/article/back/sec/--><p id="__p53" class="p p-first-last">The Belgian contribution to the project was supported by the Research Fund KU Leuven (<span>OT/11/087</span> to A.G. and B.D.), the Belgian Charcot Foundation (Research Grant to A.G.), and the Research Foundation Flanders (FWO-Vlaanderen; Clinical Investigator Fellowship to B.D.). The Norwegian part of the study was supported by The Research Council of Norway (project <span>143153</span>; and <span>196776</span>; by H.F.H.), University of Oslo (project <span>211567</span> by H.F.H.), NevroNor, Research Council of Norway (project <span>176958</span> by K.M.M.) and The Western Norway Regional Health Authority, Stavanger, Norway. The Italian contribution was supported by the Italian Foundation for Multiple Sclerosis [FISM grants ‘Progetto Speciale Immunochip’, <span>2011/R/14</span>, Fondazione cariplo (n° <span>2010‐0728</span>;)], and the CRT Foundation, Turin, Italy. The German contribution was supported by the German Ministry for Education and Research (BMBF), the German Competence Network Multiple Sclerosis (KKNMS, Control-MS, <span>01GI0917</span>;), the Deutsche Forschungsgemeinschaft (SyNergy Cluster, <span>JE 530/1‐1</span>), and the Munich Biomed Cluster M4. The Danish contribution was supported by grants from the Danish Multiple Sclerosis Society, the Danish Council for Strategic Research [grant number <span>2142‐08‐0039</span>] and the Warwara Larsen Foundation. The Spanish contribution was supported by the ‘Red Española de Esclerosis Múltiple (REEM)’ sponsored by the FEDER-FIS and the ‘Ajuts per donar Suport als Grups de Recerca de Catalunya’, sponsored by the ‘Agència de Gestió d’Ajuts Universitaris i de Recerca’ (AGAUR), Generalitat de Catalunya, Spain. P.A.G. is a recipient of the Race to erase MS Award and the European Federation for Immunogenetics Julia Bodmer Award.</p></div><div id="__sec18" class="tsec bk-sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="__sec18title">Supplementary material</h2><!--/article/back/sec/--><p id="__p54" class="p p-first-last"><a href="http://brain.oxfordjournals.org/lookup/suppl/doi:10.1093/brain/awu405/-/DC1" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">Supplementary material</a> is available at <em>Brain</em> online.</p></div><div id="idm139961275091424" class="tsec sec"><div class="goto jig-ncbiinpagenav-goto-container"><a class="tgt_dark page-toc-label jig-ncbiinpagenav-goto-heading" href="#" title="Go to other sections in this page" role="button" aria-expanded="false" aria-haspopup="true">Go to:</a></div><h2 class="head no_bottom_margin ui-helper-clearfix" id="idm139961275091424title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="awu405-B1"><span class="element-citation">Allanore Y, Saad M, Dieude P, Avouac J, Distler JH, Amouyel P, et al.  Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002091.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3131285/">PMC free article</a>]</span> [<a href="/pubmed/21750679" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genome-wide+scan+identifies+TNIP1,+PSORS1C1,+and+RHOB+as+novel+risk+loci+for+systemic+sclerosis&amp;author=Y+Allanore&amp;author=M+Saad&amp;author=P+Dieude&amp;author=J+Avouac&amp;author=JH+Distler&amp;volume=7&amp;publication_year=2011&amp;pages=e1002091&amp;pmid=21750679&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B2"><span class="element-citation">Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG. Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway. <span><span class="ref-journal">Eur J Neurol. </span>2013;<span class="ref-vol">20</span>:1546–52.</span> [<a href="/pubmed/23834430" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=Increased+disease+severity+in+non-Western+immigrants+with+multiple+sclerosis+in+Oslo,+Norway&amp;author=P+Berg-Hansen&amp;author=C+Smestad&amp;author=L+Sandvik&amp;author=HF+Harbo&amp;author=EG+Celius&amp;volume=20&amp;publication_year=2013&amp;pages=1546-52&amp;pmid=23834430&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B3"><span class="element-citation">Buck D, Albrecht E, Aslam M, Goris A, Hauenstein N, Jochim A, et al.  Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2012;<span class="ref-vol">73</span>:86–94.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3661208/">PMC free article</a>]</span> [<a href="/pubmed/23225573" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Genetic+variants+in+the+immunoglobulin+heavy+chain+locus+are+associated+with+the+IgG+index+in+multiple+sclerosis&amp;author=D+Buck&amp;author=E+Albrecht&amp;author=M+Aslam&amp;author=A+Goris&amp;author=N+Hauenstein&amp;volume=73&amp;publication_year=2012&amp;pages=86-94&amp;pmid=23225573&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B4"><span class="element-citation">Cepok S, Jacobsen M, Schock S, Omer B, Jaekel S, Boddeker I, et al.  Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. <span><span class="ref-journal">Brain. </span>2001;<span class="ref-vol">124</span>(Pt 11):2169–76.</span> [<a href="/pubmed/11673319" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Patterns+of+cerebrospinal+fluid+pathology+correlate+with+disease+progression+in+multiple+sclerosis&amp;author=S+Cepok&amp;author=M+Jacobsen&amp;author=S+Schock&amp;author=B+Omer&amp;author=S+Jaekel&amp;volume=124&amp;issue=Pt+11&amp;publication_year=2001&amp;pages=2169-76&amp;pmid=11673319&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B5"><span class="element-citation">Cepok S, Rosche B, Grummel V, Vogel F, Zhou D, Sayn J, et al.  Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. <span><span class="ref-journal">Brain. </span>2005;<span class="ref-vol">128</span>(Pt 7):1667–76.</span> [<a href="/pubmed/15800022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Short-lived+plasma+blasts+are+the+main+B+cell+effector+subset+during+the+course+of+multiple+sclerosis&amp;author=S+Cepok&amp;author=B+Rosche&amp;author=V+Grummel&amp;author=F+Vogel&amp;author=D+Zhou&amp;volume=128&amp;issue=Pt+7&amp;publication_year=2005&amp;pages=1667-76&amp;pmid=15800022&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B6"><span class="element-citation">Compston A, Coles A. Multiple sclerosis. <span><span class="ref-journal">Lancet. </span>2008;<span class="ref-vol">372</span>:1502–17.</span> [<a href="/pubmed/18970977" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Multiple+sclerosis&amp;author=A+Compston&amp;author=A+Coles&amp;volume=372&amp;publication_year=2008&amp;pages=1502-17&amp;pmid=18970977&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B7"><span class="element-citation">Dilthey AT, Moutsianas L, Leslie S, McVean G. HLA*IMP—an integrated framework for imputing classical HLA alleles from SNP genotypes. <span><span class="ref-journal">Bioinformatics. </span>2011;<span class="ref-vol">27</span>:968–72.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3065693/">PMC free article</a>]</span> [<a href="/pubmed/21300701" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=HLA*IMP—an+integrated+framework+for+imputing+classical+HLA+alleles+from+SNP+genotypes&amp;author=AT+Dilthey&amp;author=L+Moutsianas&amp;author=S+Leslie&amp;author=G+McVean&amp;volume=27&amp;publication_year=2011&amp;pages=968-72&amp;pmid=21300701&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B8"><span class="element-citation">Dobson R, Ramagopalan S, Davis A, Giovannoni G. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2013;<span class="ref-vol">84</span>:909–14.</span> [<a href="/pubmed/23431079" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=Cerebrospinal+fluid+oligoclonal+bands+in+multiple+sclerosis+and+clinically+isolated+syndromes:+a+meta-analysis+of+prevalence,+prognosis+and+effect+of+latitude&amp;author=R+Dobson&amp;author=S+Ramagopalan&amp;author=A+Davis&amp;author=G+Giovannoni&amp;volume=84&amp;publication_year=2013&amp;pages=909-14&amp;pmid=23431079&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B9"><span class="element-citation">Ferreira RC, Pan-Hammarstrom Q, Graham RR, Gateva V, Fontan G, Lee AT, et al.  Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:777–80.</span> [<a href="/pubmed/20694011" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Association+of+IFIH1+and+other+autoimmunity+risk+alleles+with+selective+IgA+deficiency&amp;author=RC+Ferreira&amp;author=Q+Pan-Hammarstrom&amp;author=RR+Graham&amp;author=V+Gateva&amp;author=G+Fontan&amp;volume=42&amp;publication_year=2010&amp;pages=777-80&amp;pmid=20694011&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B10"><span class="element-citation">Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, Miyasaka K, et al.  The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds. <span><span class="ref-journal">J Neurol Sci. </span>1998;<span class="ref-vol">158</span>:209–14.</span> [<a href="/pubmed/9702693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Sci&amp;title=The+significance+of+oligoclonal+bands+in+multiple+sclerosis+in+Japan:+relevance+of+immunogenetic+backgrounds&amp;author=T+Fukazawa&amp;author=S+Kikuchi&amp;author=H+Sasaki&amp;author=K+Hamada&amp;author=T+Hamada&amp;volume=158&amp;publication_year=1998&amp;pages=209-14&amp;pmid=9702693&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B11"><span class="element-citation">Gottenberg JE, Busson M, Loiseau P, Cohen-Solal J, Lepage V, Charron D, et al.  In primary Sjogren’s syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. <span><span class="ref-journal">Arthritis Rheum. </span>2003;<span class="ref-vol">48</span>:2240–5.</span> [<a href="/pubmed/12905478" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheum&amp;title=In+primary+Sjogren’s+syndrome,+HLA+class+II+is+associated+exclusively+with+autoantibody+production+and+spreading+of+the+autoimmune+response&amp;author=JE+Gottenberg&amp;author=M+Busson&amp;author=P+Loiseau&amp;author=J+Cohen-Solal&amp;author=V+Lepage&amp;volume=48&amp;publication_year=2003&amp;pages=2240-5&amp;pmid=12905478&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B12"><span class="element-citation">Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, et al.  Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. <span><span class="ref-journal">Ann Neurol. </span>2011;<span class="ref-vol">69</span>:65–74.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3511846/">PMC free article</a>]</span> [<a href="/pubmed/21280076" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Aggregation+of+multiple+sclerosis+genetic+risk+variants+in+multiple+and+single+case+families&amp;author=PA+Gourraud&amp;author=JP+McElroy&amp;author=SJ+Caillier&amp;author=BA+Johnson&amp;author=A+Santaniello&amp;volume=69&amp;publication_year=2011&amp;pages=65-74&amp;pmid=21280076&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B13"><span class="element-citation">Haghighi S, Andersen O, Rosengren L, Bergstrom T, Wahlstrom J, Nilsson S. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. <span><span class="ref-journal">J Neurol. </span>2000;<span class="ref-vol">247</span>:616–22.</span> [<a href="/pubmed/11041329" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol&amp;title=Incidence+of+CSF+abnormalities+in+siblings+of+multiple+sclerosis+patients+and+unrelated+controls&amp;author=S+Haghighi&amp;author=O+Andersen&amp;author=L+Rosengren&amp;author=T+Bergstrom&amp;author=J+Wahlstrom&amp;volume=247&amp;publication_year=2000&amp;pages=616-22&amp;pmid=11041329&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B14"><span class="element-citation">Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, et al.  Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis. <span><span class="ref-journal">Mult Scler. </span>2014;<span class="ref-vol">20</span>:660–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4066985/">PMC free article</a>]</span> [<a href="/pubmed/24099750" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=Oligoclonal+bands+and+age+at+onset+correlate+with+genetic+risk+score+in+multiple+sclerosis&amp;author=HF+Harbo&amp;author=N+Isobe&amp;author=P+Berg-Hansen&amp;author=SD+Bos&amp;author=SJ+Caillier&amp;volume=20&amp;publication_year=2014&amp;pages=660-8&amp;pmid=24099750&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B15"><span class="element-citation">Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, et al.  HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2002;<span class="ref-vol">72</span>:184–7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1737743/">PMC free article</a>]</span> [<a href="/pubmed/11796767" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Neurosurg+Psychiatry&amp;title=HLA-DR+15+is+associated+with+female+sex+and+younger+age+at+diagnosis+in+multiple+sclerosis&amp;author=AE+Hensiek&amp;author=SJ+Sawcer&amp;author=R+Feakes&amp;author=J+Deans&amp;author=A+Mander&amp;volume=72&amp;publication_year=2002&amp;pages=184-7&amp;pmid=11796767&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B16"><span class="element-citation">Huss DJ, Winger RC, Cox GM, Guerau-de-Arellano M, Yang Y, Racke MK, et al.  TGF-beta signaling via Smad4 drives IL-10 production in effector Th1 cells and reduces T-cell trafficking in EAE. <span><span class="ref-journal">Eur J Immunol. </span>2011;<span class="ref-vol">41</span>:2987–96.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3478765/">PMC free article</a>]</span> [<a href="/pubmed/21728174" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=TGF-beta+signaling+via+Smad4+drives+IL-10+production+in+effector+Th1+cells+and+reduces+T-cell+trafficking+in+EAE&amp;author=DJ+Huss&amp;author=RC+Winger&amp;author=GM+Cox&amp;author=M+Guerau-de-Arellano&amp;author=Y+Yang&amp;volume=41&amp;publication_year=2011&amp;pages=2987-96&amp;pmid=21728174&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B17"><span class="element-citation">Idiman E, Ozakbas S, Dogan Y, Kosehasanogullari G. The significance of oligoclonal bands in multiple sclerosis: relevance of demographic and clinical features, and immunogenetic backgrounds. <span><span class="ref-journal">J Neuroimmunol. </span>2009;<span class="ref-vol">212</span>:121–4.</span> [<a href="/pubmed/19457560" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;title=The+significance+of+oligoclonal+bands+in+multiple+sclerosis:+relevance+of+demographic+and+clinical+features,+and+immunogenetic+backgrounds&amp;author=E+Idiman&amp;author=S+Ozakbas&amp;author=Y+Dogan&amp;author=G+Kosehasanogullari&amp;volume=212&amp;publication_year=2009&amp;pages=121-4&amp;pmid=19457560&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B18"><span class="element-citation">Imrell K, Landtblom AM, Hillert J, Masterman T. Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. <span><span class="ref-journal">Neurology. </span>2006;<span class="ref-vol">67</span>:1062–4.</span> [<a href="/pubmed/17000979" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Multiple+sclerosis+with+and+without+CSF+bands:+clinically+indistinguishable+but+immunogenetically+distinct&amp;author=K+Imrell&amp;author=AM+Landtblom&amp;author=J+Hillert&amp;author=T+Masterman&amp;volume=67&amp;publication_year=2006&amp;pages=1062-4&amp;pmid=17000979&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B19"><span class="element-citation">Ishii M, Hasegawa G, Fukui M, Obayashi H, Ohta M, Ogata M, et al.  Clinical and genetic characteristics of diabetic patients with high-titer (&gt;10,000 U/ml) of antibodies to glutamic acid decarboxylase. <span><span class="ref-journal">Immunol Lett. </span>2005;<span class="ref-vol">99</span>:180–5.</span> [<a href="/pubmed/16009268" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Lett&amp;title=Clinical+and+genetic+characteristics+of+diabetic+patients+with+high-titer+(>10,000+U/ml)+of+antibodies+to+glutamic+acid+decarboxylase&amp;author=M+Ishii&amp;author=G+Hasegawa&amp;author=M+Fukui&amp;author=H+Obayashi&amp;author=M+Ohta&amp;volume=99&amp;publication_year=2005&amp;pages=180-5&amp;pmid=16009268&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B20"><span class="element-citation">Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. <span><span class="ref-journal">Lancet. </span>1972;<span class="ref-vol">1</span>:1240–1.</span> [<a href="/pubmed/4113225" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=HL-A+antigens+and+multiple+sclerosis&amp;author=C+Jersild&amp;author=A+Svejgaard&amp;author=T+Fog&amp;volume=1&amp;publication_year=1972&amp;pages=1240-1&amp;pmid=4113225&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B21"><span class="element-citation">Kikuchi S, Fukazawa T, Niino M, Yabe I, Miyagishi R, Hamada T, et al.  HLA-related subpopulations of MS in Japanese with and without oligoclonal IgG bands. <span><span class="ref-journal">Human leukocyte antigen. Neurology. </span>2003;<span class="ref-vol">60</span>:647–51.</span> [<a href="/pubmed/12601107" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+leukocyte+antigen.+Neurology&amp;title=HLA-related+subpopulations+of+MS+in+Japanese+with+and+without+oligoclonal+IgG+bands&amp;author=S+Kikuchi&amp;author=T+Fukazawa&amp;author=M+Niino&amp;author=I+Yabe&amp;author=R+Miyagishi&amp;volume=60&amp;publication_year=2003&amp;pages=647-51&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B22"><span class="element-citation">Lechner-Scott J, Spencer B, de Malmanche T, Attia J, Fitzgerald M, Trojano M, et al.  The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude. <span><span class="ref-journal">Mult Scler. </span>2011;<span class="ref-vol">18</span>:974–82.</span> [<a href="/pubmed/22185806" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mult+Scler&amp;title=The+frequency+of+CSF+oligoclonal+banding+in+multiple+sclerosis+increases+with+latitude&amp;author=J+Lechner-Scott&amp;author=B+Spencer&amp;author=T+de+Malmanche&amp;author=J+Attia&amp;author=M+Fitzgerald&amp;volume=18&amp;publication_year=2011&amp;pages=974-82&amp;pmid=22185806&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B23"><span class="element-citation">Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, et al.  Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e64408.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3681825/">PMC free article</a>]</span> [<a href="/pubmed/23785401" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Association+of+genetic+markers+with+CSF+oligoclonal+bands+in+multiple+sclerosis+patients&amp;author=MA+Leone&amp;author=N+Barizzone&amp;author=F+Esposito&amp;author=A+Lucenti&amp;author=HF+Harbo&amp;volume=8&amp;publication_year=2013&amp;pages=e64408&amp;pmid=23785401&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B24"><span class="element-citation">Link H, Huang YM. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. <span><span class="ref-journal">J Neuroimmunol. </span>2006;<span class="ref-vol">180</span>:17–28.</span> [<a href="/pubmed/16945427" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;title=Oligoclonal+bands+in+multiple+sclerosis+cerebrospinal+fluid:+an+update+on+methodology+and+clinical+usefulness&amp;author=H+Link&amp;author=YM+Huang&amp;volume=180&amp;publication_year=2006&amp;pages=17-28&amp;pmid=16945427&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B25"><span class="element-citation">Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al.  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. <span><span class="ref-journal">Brain. </span>2007;<span class="ref-vol">130</span>(Pt 4):1089–104.</span> [<a href="/pubmed/17438020" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain&amp;title=Meningeal+B-cell+follicles+in+secondary+progressive+multiple+sclerosis+associate+with+early+onset+of+disease+and+severe+cortical+pathology&amp;author=R+Magliozzi&amp;author=O+Howell&amp;author=A+Vora&amp;author=B+Serafini&amp;author=R+Nicholas&amp;volume=130&amp;issue=Pt+4&amp;publication_year=2007&amp;pages=1089-104&amp;pmid=17438020&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B26"><span class="element-citation">Mayringer I, Timeltaler B, Deisenhammer F. Correlation between the IgG index, oligoclonal bands in CSF, and the diagnosis of demyelinating diseases. <span><span class="ref-journal">Eur J Neurol. </span>2005;<span class="ref-vol">12</span>:527–30.</span> [<a href="/pubmed/15958092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=Correlation+between+the+IgG+index,+oligoclonal+bands+in+CSF,+and+the+diagnosis+of+demyelinating+diseases&amp;author=I+Mayringer&amp;author=B+Timeltaler&amp;author=F+Deisenhammer&amp;volume=12&amp;publication_year=2005&amp;pages=527-30&amp;pmid=15958092&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B27"><span class="element-citation">McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:121–7.</span> [<a href="/pubmed/11456302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Recommended+diagnostic+criteria+for+multiple+sclerosis:+guidelines+from+the+International+Panel+on+the+diagnosis+of+multiple+sclerosis&amp;author=WI+McDonald&amp;author=A+Compston&amp;author=G+Edan&amp;author=D+Goodkin&amp;author=HP+Hartung&amp;volume=50&amp;publication_year=2001&amp;pages=121-7&amp;pmid=11456302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B28"><span class="element-citation">Meoli EM, Oh U, Grant CW, Jacobson S. TGF-beta signaling is altered in the peripheral blood of subjects with multiple sclerosis. <span><span class="ref-journal">J Neuroimmunol. </span>2010;<span class="ref-vol">230</span>:164–8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4988390/">PMC free article</a>]</span> [<a href="/pubmed/21093933" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;title=TGF-beta+signaling+is+altered+in+the+peripheral+blood+of+subjects+with+multiple+sclerosis&amp;author=EM+Meoli&amp;author=U+Oh&amp;author=CW+Grant&amp;author=S+Jacobson&amp;volume=230&amp;publication_year=2010&amp;pages=164-8&amp;pmid=21093933&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B29"><span class="element-citation">Mero IL, Gustavsen MW, Saether HS, Flam ST, Berg-Hansen P, Sondergaard HB, et al.  Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e58352.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3589422/">PMC free article</a>]</span> [<a href="/pubmed/23472185" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Oligoclonal+band+status+in+Scandinavian+multiple+sclerosis+patients+is+associated+with+specific+genetic+risk+alleles&amp;author=IL+Mero&amp;author=MW+Gustavsen&amp;author=HS+Saether&amp;author=ST+Flam&amp;author=P+Berg-Hansen&amp;volume=8&amp;publication_year=2013&amp;pages=e58352&amp;pmid=23472185&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B30"><span class="element-citation">Oak S, Gaur LK, Radtke J, Patel R, Iyer D, Ram N, et al.  “Masked” and overt autoantibodies specific to the DPD epitope of 65 kDa glutamate decarboxylase (GAD65-DPD) are associated with preserved beta cell functional reserve in Ketosis-Prone Diabetes. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2014;<span class="ref-vol">99</span>:E1040–4.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4037721/">PMC free article</a>]</span> [<a href="/pubmed/24601691" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Endocrinol+Metab&amp;title=“Masked”+and+overt+autoantibodies+specific+to+the+DPD+epitope+of+65+kDa+glutamate+decarboxylase+(GAD65-DPD)+are+associated+with+preserved+beta+cell+functional+reserve+in+Ketosis-Prone+Diabetes&amp;author=S+Oak&amp;author=LK+Gaur&amp;author=J+Radtke&amp;author=R+Patel&amp;author=D+Iyer&amp;volume=99&amp;publication_year=2014&amp;pages=E1040-4&amp;pmid=24601691&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B31"><span class="element-citation">Orozco G, Viatte S, Bowes J, Martin P, Wilson AG, Morgan AW, et al.  Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study. <span><span class="ref-journal">Arthritis Rheumatol. </span>2014;<span class="ref-vol">66</span>:24–30.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4285161/">PMC free article</a>]</span> [<a href="/pubmed/24449572" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arthritis+Rheumatol&amp;title=Novel+rheumatoid+arthritis+susceptibility+locus+at+22q12+identified+in+an+extended+UK+genome-wide+association+study&amp;author=G+Orozco&amp;author=S+Viatte&amp;author=J+Bowes&amp;author=P+Martin&amp;author=AG+Wilson&amp;volume=66&amp;publication_year=2014&amp;pages=24-30&amp;pmid=24449572&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B32"><span class="element-citation">Ovsyannikova IG, Kennedy RB, O’Byrne M, Jacobson RM, Pankratz VS, Poland GA. Genome-wide association study of antibody response to smallpox vaccine. <span><span class="ref-journal">Vaccine. </span>2012;<span class="ref-vol">30</span>:4182–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3367131/">PMC free article</a>]</span> [<a href="/pubmed/22542470" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Genome-wide+association+study+of+antibody+response+to+smallpox+vaccine&amp;author=IG+Ovsyannikova&amp;author=RB+Kennedy&amp;author=M+O’Byrne&amp;author=RM+Jacobson&amp;author=VS+Pankratz&amp;volume=30&amp;publication_year=2012&amp;pages=4182-9&amp;pmid=22542470&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B33"><span class="element-citation">Pandey JP. Immunoglobulin GM allotypes in multiple sclerosis. <span><span class="ref-journal">Ann Neurol. </span>2013;<span class="ref-vol">73</span>:148.</span> [<a href="/pubmed/23378332" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=Immunoglobulin+GM+allotypes+in+multiple+sclerosis&amp;author=JP+Pandey&amp;volume=73&amp;publication_year=2013&amp;pages=148&amp;pmid=23378332&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B34"><span class="element-citation">Park SR, Seo GY, Choi AJ, Stavnezer J, Kim PH. Analysis of transforming growth factor-beta1-induced Ig germ-line gamma2b transcription and its implication for IgA isotype switching. <span><span class="ref-journal">Eur J Immunol. </span>2005;<span class="ref-vol">35</span>:946–56.</span> [<a href="/pubmed/15688346" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=Analysis+of+transforming+growth+factor-beta1-induced+Ig+germ-line+gamma2b+transcription+and+its+implication+for+IgA+isotype+switching&amp;author=SR+Park&amp;author=GY+Seo&amp;author=AJ+Choi&amp;author=J+Stavnezer&amp;author=PH+Kim&amp;volume=35&amp;publication_year=2005&amp;pages=946-56&amp;pmid=15688346&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B35"><span class="element-citation">Plagnol V, Howson JM, Smyth DJ, Walker N, Hafler JP, Wallace C, et al.  Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. <span><span class="ref-journal">PLoS Genet. </span>2011;<span class="ref-vol">7</span>:e1002216.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3150451/">PMC free article</a>]</span> [<a href="/pubmed/21829393" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=Genome-wide+association+analysis+of+autoantibody+positivity+in+type+1+diabetes+cases&amp;author=V+Plagnol&amp;author=JM+Howson&amp;author=DJ+Smyth&amp;author=N+Walker&amp;author=JP+Hafler&amp;volume=7&amp;publication_year=2011&amp;pages=e1002216&amp;pmid=21829393&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B36"><span class="element-citation">Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols. <span><span class="ref-journal">Ann Neurol. </span>1983;<span class="ref-vol">13</span>:227–31.</span> [<a href="/pubmed/6847134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Neurol&amp;title=New+diagnostic+criteria+for+multiple+sclerosis:+guidelines+for+research+protocols&amp;author=CM+Poser&amp;author=DW+Paty&amp;author=L+Scheinberg&amp;author=WI+McDonald&amp;author=FA+Davis&amp;volume=13&amp;publication_year=1983&amp;pages=227-31&amp;pmid=6847134&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B37"><span class="element-citation">Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">81</span>:559–75.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1950838/">PMC free article</a>]</span> [<a href="/pubmed/17701901" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Hum+Genet&amp;title=PLINK:+a+tool+set+for+whole-genome+association+and+population-based+linkage+analyses&amp;author=S+Purcell&amp;author=B+Neale&amp;author=K+Todd-Brown&amp;author=L+Thomas&amp;author=MA+Ferreira&amp;volume=81&amp;publication_year=2007&amp;pages=559-75&amp;pmid=17701901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B38"><span class="element-citation">Radstake TR, Gorlova O, Rueda B, Martin JE, Alizadeh BZ, Palomino-Morales R, et al.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. <span><span class="ref-journal">Nat Genet. </span>2010;<span class="ref-vol">42</span>:426–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2861917/">PMC free article</a>]</span> [<a href="/pubmed/20383147" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Genome-wide+association+study+of+systemic+sclerosis+identifies+CD247+as+a+new+susceptibility+locus&amp;author=TR+Radstake&amp;author=O+Gorlova&amp;author=B+Rueda&amp;author=JE+Martin&amp;author=BZ+Alizadeh&amp;volume=42&amp;publication_year=2010&amp;pages=426-9&amp;pmid=20383147&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B39"><span class="element-citation">Rinker JR, Trinkaus K, II, Naismith RT, Cross AH. Higher IgG index found in African Americans versus Caucasians with multiple sclerosis. <span><span class="ref-journal">Neurology. </span>2007;<span class="ref-vol">69</span>:68–72.</span> [<a href="/pubmed/17606883" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Higher+IgG+index+found+in+African+Americans+versus+Caucasians+with+multiple+sclerosis&amp;author=JR+Rinker&amp;author=K+Trinkaus&amp;author=RT+Naismith&amp;author=AH+Cross&amp;volume=69&amp;publication_year=2007&amp;pages=68-72&amp;pmid=17606883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B40"><span class="element-citation">Romero-Pinel L, Martinez-Yelamos S, Bau L, Matas E, Gubieras L, Maria Pujal J, et al.  Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. <span><span class="ref-journal">Eur J Neurol. </span>2011;<span class="ref-vol">18</span>:1258–62.</span> [<a href="/pubmed/21418440" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Neurol&amp;title=Association+of+HLA-DRB1*15+allele+and+CSF+oligoclonal+bands+in+a+Spanish+multiple+sclerosis+cohort&amp;author=L+Romero-Pinel&amp;author=S+Martinez-Yelamos&amp;author=L+Bau&amp;author=E+Matas&amp;author=L+Gubieras&amp;volume=18&amp;publication_year=2011&amp;pages=1258-62&amp;pmid=21418440&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B41"><span class="element-citation">Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, et al.  Multiple sclerosis severity score: using disability and disease duration to rate disease severity. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:1144–51.</span> [<a href="/pubmed/15824338" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Multiple+sclerosis+severity+score:+using+disability+and+disease+duration+to+rate+disease+severity&amp;author=RH+Roxburgh&amp;author=SR+Seaman&amp;author=T+Masterman&amp;author=AE+Hensiek&amp;author=SJ+Sawcer&amp;volume=64&amp;publication_year=2005&amp;pages=1144-51&amp;pmid=15824338&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B42"><span class="element-citation">Rubicz R, Yolken R, Drigalenko E, Carless MA, Dyer TD, Bauman L, et al.  A Genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr Virus Nuclear Antigen 1 (EBNA-1) <span><span class="ref-journal">PLoS Genet. </span>2013;<span class="ref-vol">9</span>:e1003147.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3542101/">PMC free article</a>]</span> [<a href="/pubmed/23326239" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Genet&amp;title=A+Genome-wide+integrative+genomic+study+localizes+genetic+factors+influencing+antibodies+against+Epstein-Barr+Virus+Nuclear+Antigen+1+(EBNA-1)&amp;author=R+Rubicz&amp;author=R+Yolken&amp;author=E+Drigalenko&amp;author=MA+Carless&amp;author=TD+Dyer&amp;volume=9&amp;publication_year=2013&amp;pages=e1003147&amp;pmid=23326239&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B43"><span class="element-citation">Rudick RA, Cookfair DL, Simonian NA, Ransohoff RM, Richert JR, Jacobs LD, et al.  Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The multiple sclerosis collaborative research group. <span><span class="ref-journal">J Neuroimmunol. </span>1999;<span class="ref-vol">93</span>:8–14.</span> [<a href="/pubmed/10378864" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neuroimmunol&amp;title=Cerebrospinal+fluid+abnormalities+in+a+phase+III+trial+of+Avonex+(IFNbeta-1a)+for+relapsing+multiple+sclerosis.+The+multiple+sclerosis+collaborative+research+group&amp;author=RA+Rudick&amp;author=DL+Cookfair&amp;author=NA+Simonian&amp;author=RM+Ransohoff&amp;author=JR+Richert&amp;volume=93&amp;publication_year=1999&amp;pages=8-14&amp;pmid=10378864&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B44"><span class="element-citation">Stangel M, Fredrikson S, Meinl E, Petzold A, Stuve O, Tumani H. The utility of cerebrospinal fluid analysis in patients with multiple sclerosis. <span><span class="ref-journal">Nat Rev Neurol. </span>2013;<span class="ref-vol">9</span>:267–76.</span> [<a href="/pubmed/23528543" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Neurol&amp;title=The+utility+of+cerebrospinal+fluid+analysis+in+patients+with+multiple+sclerosis&amp;author=M+Stangel&amp;author=S+Fredrikson&amp;author=E+Meinl&amp;author=A+Petzold&amp;author=O+Stuve&amp;volume=9&amp;publication_year=2013&amp;pages=267-76&amp;pmid=23528543&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B45"><span class="element-citation">Sundqvist E, Buck D, Warnke C, Albrecht E, Gieger C, Khademi M, et al.  JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants. <span><span class="ref-journal">PLoS Pathog. </span>2014;<span class="ref-vol">10</span>:e1004084.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3999271/">PMC free article</a>]</span> [<a href="/pubmed/24763718" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Pathog&amp;title=JC+polyomavirus+infection+is+strongly+controlled+by+human+leucocyte+antigen+class+II+variants&amp;author=E+Sundqvist&amp;author=D+Buck&amp;author=C+Warnke&amp;author=E+Albrecht&amp;author=C+Gieger&amp;volume=10&amp;publication_year=2014&amp;pages=e1004084&amp;pmid=24763718&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B46"><span class="element-citation">The International MHC and Autoimmunity Genetics Network. Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2009;<span class="ref-vol">106</span>:18680–5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2773992/">PMC free article</a>]</span> [<a href="/pubmed/19846760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Mapping+of+multiple+susceptibility+variants+within+the+MHC+region+for+7+immune-mediated+diseases&amp;volume=106&amp;publication_year=2009&amp;pages=18680-5&amp;pmid=19846760&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B47"><span class="element-citation">The International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:1353–60.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3832895/">PMC free article</a>]</span> [<a href="/pubmed/24076602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Analysis+of+immune-related+loci+identifies+48+new+susceptibility+variants+for+multiple+sclerosis&amp;volume=45&amp;publication_year=2013&amp;pages=1353-60&amp;pmid=24076602&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B48"><span class="element-citation">The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">476</span>:214–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3182531/">PMC free article</a>]</span> [<a href="/pubmed/21833088" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Genetic+risk+and+a+primary+role+for+cell-mediated+immune+mechanisms+in+multiple+sclerosis&amp;volume=476&amp;publication_year=2011&amp;pages=214-9&amp;pmid=21833088&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B49"><span class="element-citation">Tintore M, Rovira A, Rio J, Tur C, Pelayo R, Nos C, et al.  Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? <span><span class="ref-journal">Neurology. </span>2008;<span class="ref-vol">70</span>(13 Pt 2):1079–83.</span> [<a href="/pubmed/17881717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurology&amp;title=Do+oligoclonal+bands+add+information+to+MRI+in+first+attacks+of+multiple+sclerosis?&amp;author=M+Tintore&amp;author=A+Rovira&amp;author=J+Rio&amp;author=C+Tur&amp;author=R+Pelayo&amp;volume=70&amp;issue=13+Pt+2&amp;publication_year=2008&amp;pages=1079-83&amp;pmid=17881717&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B50"><span class="element-citation">Wu JS, Qiu W, Castley A, James I, Joseph J, Christiansen FT, et al.  Presence of CSF oligoclonal bands (OCB) is associated with the HLA-DRB1 genotype in a West Australian multiple sclerosis cohort. <span><span class="ref-journal">J Neurol Sci. </span>2009;<span class="ref-vol">288</span>:63–7.</span> [<a href="/pubmed/19879597" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Neurol+Sci&amp;title=Presence+of+CSF+oligoclonal+bands+(OCB)+is+associated+with+the+HLA-DRB1+genotype+in+a+West+Australian+multiple+sclerosis+cohort&amp;author=JS+Wu&amp;author=W+Qiu&amp;author=A+Castley&amp;author=I+James&amp;author=J+Joseph&amp;volume=288&amp;publication_year=2009&amp;pages=63-7&amp;pmid=19879597&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li><li id="awu405-B51"><span class="element-citation">Yoshimura S, Isobe N, Matsushita T, Masaki K, Sato S, Kawano Y, et al.  Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients. <span><span class="ref-journal">PLoS One. </span>2014;<span class="ref-vol">9</span>:e95367.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3988235/">PMC free article</a>]</span> [<a href="/pubmed/24736746" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+One&amp;title=Genetic+and+infectious+profiles+influence+cerebrospinal+fluid+IgG+abnormality+in+Japanese+multiple+sclerosis+patients&amp;author=S+Yoshimura&amp;author=N+Isobe&amp;author=T+Matsushita&amp;author=K+Masaki&amp;author=S+Sato&amp;volume=9&amp;publication_year=2014&amp;pages=e95367&amp;pmid=24736746&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=4408440&amp;issue-id=249814&amp;journal-id=719&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar" role="button" aria-expanded="false" aria-haspopup="true">Google Scholar</a>]</span></span></li></ul></div></div><div style="display: none; width: 200px; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbilinksmenu"><ul id="ui-ncbiinpagenav-2"><li><a href="#idm139961284889376title">Abstract</a></li><li><a href="#__sec1title">Introduction</a></li><li><a href="#__sec2title">Materials and methods</a></li><li><a href="#__sec11title">Results</a></li><li><a href="#__sec16title">Discussion</a></li><li><a href="#idm139961279385136title">Acknowledgements</a></li><li><a href="#idm139961280744496title">Glossary</a></li><li><a href="#__sec17title">Funding</a></li><li><a href="#__sec18title">Supplementary material</a></li><li><a href="#idm139961275091424title">References</a></li></ul></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr>Articles from <span class="acknowledgment-journal-title">Brain</span> are provided here courtesy of <strong>Oxford University Press</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4408440/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4408440/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4408440/pdf/awu405.pdf">PDF (407K)</a></li> | <li><a href="#" data-citationid="PMC4408440" class="citationexporter ctxp" role="button" aria-expanded="false" aria-haspopup="true">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408440%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook">
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408440%2F&amp;text=Genetic%20variants%20are%20major%20determinants%20of%20CSF%20antibody%20levels%20in%20multiple%20sclerosis" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter">
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408440%2F" role="button" aria-expanded="false" aria-haspopup="true" target="_blank"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus">
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="25616667" data-aiid="4408440" data-aid="4408440" data-iid="249814" data-domainid="719" data-domain="brain" data-accid="PMC4408440" data-md5="16f8ea3a30996d4f3388a178564c0667"><img src="/portal/portal3rc.fcgi/4018218/img/3631476" alt="Loading..." align="absmiddle"> Loading portlets...</div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-11-20T13:15:17-05:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal102&amp;ncbi_phid=CE898D1DDD5765C10000000008210504&amp;ncbi_session=CE8C6010DD4F8B31_0740SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4408440%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        <div class="ui-ncbiautocomplete-holder shadow ui-ncbiautocomplete-holder-clearfix" aria-live="assertive" style="display: none; top: 68.1px; left: 377.2px; width: 670px; z-index: 1001;"><ul class="ui-ncbiautocomplete-options" role="listbox" aria-activedescendant="term"></ul><div class="ui-ncbiautocomplete-actions shadow" style="display: block;"><a class="ui-ncbiautocomplete-link-pref" style="display: none;">Preferences</a><a href="#" class="ui-ncbiautocomplete-link-off ui-ncbiautocomplete-link-pref-right" style="display: block;">Turn off</a></div></div><div style="display: none; top: -100px; left: -100px;" aria-live="assertive" aria-hidden="true" class="ui-helper-reset ui-ncbipopper-wrapper ui-ncbipopper-basic">External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.</div></div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=brain&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4408440/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6010DD4F8B31_0740SID /projects/PMC/PMCViewer@4.46 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script>
<div class="ui-dialog ui-widget ui-widget-content ui-corner-all ui-front" style="display: none;" tabindex="-1" role="dialog" aria-describedby="epubDialog" aria-labelledby="ui-id-1"><div class="ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix"><span id="ui-id-1" class="ui-dialog-title">Making articles easier to read in PMC</span><button type="button" class="ui-button ui-widget ui-state-default ui-corner-all ui-button-icon-only ui-dialog-titlebar-close" role="button" title="Close"><span class="ui-button-icon-primary ui-icon ui-icon-closethick"></span><span class="ui-button-text">Close</span></button></div><div id="epubDialog" style="display: block;" class="ui-dialog-content ui-widget-content">  <p>We are experimenting with display styles that make it easier to read articles     in PMC.     Our first effort uses eBook readers, which have several "ease of reading"     features already built in.</p>  <p>These PMC articles are best viewed in the <em>iBooks     reader</em>. You may notice problems with the display of certain parts of an article     in other eReaders.</p>  <div class="ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"><button id="cancelEpub" class="ui-state-default ui-corner-all">Cancel</button><button id="downloadEpub" style="float: left" class="ui-state-default ui-corner-all">Download article</button></div>          </div></div></body></html>